Federal Trade Commission (2007)

Agency decision

Ask Donna

What actually matters in this document.

Text

Federal Trade Commission

Bureau of Competition

Jeffrey Schmidt, Director

Antitrust Enforcement Activities

Fiscal Year 2003 - March 31, 2007

ABA Antitrust Section Spring Meeting 2007

ABA ANTITRUST SECTION

SPRING MEETING

Summary of Bureau of Competition Activity

Fiscal Year 2003 Through March 31, 2007

Table of Contents

I.

Mergers ........................................................................................................1

A.

Consent Orders .............................................................................................................. 1

American Air Liquide, Inc. ........................................................................................... 1

Allergan, Inc. .................................................................................................................. 2

Aspen Technology, Inc. ................................................................................................. 2

Baxter International, Inc............................................................................................... 2

Barr Pharmaceutical, Inc.............................................................................................. 2

Buckeye Partners, L.P. .................................................................................................. 2

Boston Scientific Corp ................................................................................................... 3

Cemex, S.A...................................................................................................................... 3

Cephalon, Inc.................................................................................................................. 3

Chevron Texaco Corporation ....................................................................................... 3

Cytec Industries, Inc...................................................................................................... 3

Dainippon Ink and Chemicals, Inc............................................................................... 3

DaVita Inc....................................................................................................................... 4

DSM N.V......................................................................................................................... 4

Enterprise Products Partners L.P. ............................................................................... 4

Enterprise Products Partners L.P. ............................................................................... 4

Fresenius AG .................................................................................................................. 4

GenCorp Inc. .................................................................................................................. 4

General Dynamics Corporation.................................................................................... 5

General Electric Company............................................................................................ 5

General Electric Company............................................................................................ 5

Genzyme Corporation ................................................................................................... 5

Hologic, Inc..................................................................................................................... 5

Hospira, Inc. ................................................................................................................... 6

Itron, Inc. ........................................................................................................................ 6

Johnson & Johnson........................................................................................................ 6

Johnson & Johnson........................................................................................................ 6

Kinder Morgan, Inc. ...................................................................................................... 6

Libbey, Inc. ..................................................................................................................... 7

Linde, AG........................................................................................................................ 7

Magellan Midstream Partners, L.P.............................................................................. 7

MSC. Software Corporation ......................................................................................... 7

Novartis AG.................................................................................................................... 8

Occidental Chemical Corporation................................................................................ 8

Penn National Gaming, Inc........................................................................................... 8

i

B.

C.

D.

E.

F.

G.

H.

II.

Pfizer Inc......................................................................................................................... 8

Phillips Petroleum Company ........................................................................................ 8

Quest Diagnostics, Inc. .................................................................................................. 8

Sanofi-Synthélabo .......................................................................................................... 9

Service Corporation International ............................................................................... 9

Shell Oil Company ......................................................................................................... 9

Southern Union Company............................................................................................. 9

Teva Pharmaceutical Industries Ltd............................................................................ 9

The Procter & Gamble Company ................................................................................ 9

The Boeing Company .................................................................................................. 10

Thermo Electron Corporation.................................................................................... 10

Valero L.P..................................................................................................................... 10

Wal-Mart Stores, Inc. .................................................................................................. 10

Watson Pharmaceuticals, Inc. .................................................................................... 11

Authorizations to Seek Preliminary Injunctions ...................................................... 11

Aloha Petroleum, Ltd .................................................................................................. 11

Arch Coal, Inc. ............................................................................................................. 11

Kroger Company/Raley’s Corporation ..................................................................... 11

Nestlé Holdings, Inc. .................................................................................................... 11

Vlasic Pickle Company ................................................................................................ 12

Commission Opinions/Initial Decisions ..................................................................... 12

Chicago Bridge & Iron Company .............................................................................. 12

Northwestern Healthcare Corporation...................................................................... 12

Court Decisions ............................................................................................................ 13

Arch Coal, Inc. ............................................................................................................. 13

Order Violations........................................................................................................... 13

Boston Scientific Corporation..................................................................................... 13

RHI AG ......................................................................................................................... 14

Other Commission Orders .......................................................................................... 14

Administrative Complaints ......................................................................................... 14

Equitable Resources, Inc. ............................................................................................ 14

Other ............................................................................................................................. 14

Horizontal Merger Investigation Data....................................................................... 14

Conference on the Price Effects of Mergers and Concentration in the United

States Petroleum Industry........................................................................................... 15

Horizontal Merger Investigation Data....................................................................... 15

Merger Efficiency Roundtable.................................................................................... 15

Merger Enforcement Workshop ................................................................................ 15

Merger Remedies - Second Workshop....................................................................... 15

Hart-Scott-Rodino Antitrust Improvements Act Enforcement ...........16

A.

B.

C.

Court Decisions ............................................................................................................ 16

Scott R. Sacane ............................................................................................................. 16

William H. Gates, III ................................................................................................... 16

Consent Orders ............................................................................................................ 16

Complaints - Filed........................................................................................................ 16

Blockbuster, Inc. .......................................................................................................... 16

ii

D.

E.

F.

III.

A.

B.

C.

D.

Complaints - Authorized ............................................................................................. 17

Arch Coal, Inc. ............................................................................................................. 17

Rules and Formal Interpretations.............................................................................. 17

Other ............................................................................................................................. 18

Non-Merger Enforcement ........................................................................19

Commission Opinions/Initial Decisions ..................................................................... 19

Kentucky Household Goods Carriers Association, Inc. ........................................... 19

North Texas Specialty Physicians............................................................................... 19

Rambus, Inc.................................................................................................................. 20

South Carolina State Board of Dentistry................................................................... 21

Union Oil of California................................................................................................ 21

Court Decisions ............................................................................................................ 21

PolyGram Holding, Inc. (The Three Tenors)............................................................ 21

Schering-Plough Corporation..................................................................................... 22

Authorizations to Seek Preliminary/Permanent Injunctions .................................. 22

Alpharma, Inc. and Perrigo Company ...................................................................... 22

Warner Chilcott ........................................................................................................... 23

Consent Orders ............................................................................................................ 23

Advocate Health Partners ........................................................................................... 23

Alabama Trucking Association, Inc........................................................................... 23

American Institute for Conservation of Historic and Artistic Works .................... 23

Anesthesia Service Medical Group, Inc. and Grossmont Anesthesia Services

Medical Group ............................................................................................................. 24

Austin Board of Realtors............................................................................................. 24

Biovail Corporation ..................................................................................................... 24

Bristol-Myers Squibb Company................................................................................. 24

California Pacific Medical Group dba Brown and Toland Medical Group........... 25

Carlsbad Physician Association.................................................................................. 25

Clark County, Washington Attorneys ....................................................................... 25

Evanston Northwestern Healthcare Corporation..................................................... 25

Health Care Alliance of Laredo, L.C., ....................................................................... 25

Indiana Household Movers and Warehousemen, Inc. ............................................. 26

Information and Real Estate Services, LLC.............................................................. 26

Institute of Store Planners........................................................................................... 26

Iowa Movers and Warehousemen’s Association....................................................... 26

Maine Health Alliance ................................................................................................. 26

Memorial Hermann Health Network Providers ....................................................... 26

Minnesota Transport Services Association ............................................................... 26

MiRealSource, Inc........................................................................................................ 27

Missouri Board of Embalmers and Funeral Directors............................................. 27

Monmouth County Association of Realtors .............................................................. 27

Movers Conference of Mississippi, Inc. ..................................................................... 27

National Academy of Arbitrators............................................................................... 27

New Hampshire Motor Transport Association......................................................... 28

New Century Health Quality Alliance, Inc................................................................ 28

New Millennium Orthopaedics................................................................................... 28

iii

E.

F.

IV.

V.

VI.

A.

B.

C.

D.

E.

Northern New England Real Estate Network, Inc.................................................... 28

Partners Health Network, Inc..................................................................................... 28

Physician Network Consulting, L.L.C. ...................................................................... 28

Piedmont Health Alliance, Inc. ................................................................................... 29

Preferred Health Services, Inc.................................................................................... 29

Professionals in Women’s Care .................................................................................. 29

Puerto Rico Association of Endodontists, Corp. ....................................................... 29

Realtors Association of Northeast Wisconsin, Inc. ................................................... 30

San Juan IPA................................................................................................................ 30

Southeastern New Mexico Physicians IPA ................................................................ 30

South Georgia Health Partners, L.L.C. ..................................................................... 30

SPA Health Organization dba Southwest Physician Associates.............................. 30

Surgical Specialists of Yakima.................................................................................... 30

Tenet Healthcare Corporation.................................................................................... 31

Union Oil Company of California .............................................................................. 31

Valassis Communications, Inc. ................................................................................... 31

Virginia Board of Funeral Directors and Embalmers.............................................. 31

Washington University Physician Network............................................................... 32

White Sands Health Care System, L.L.C. ................................................................. 32

Williamsburg Area Association of Realtors, Inc....................................................... 32

Administrative Complaints ......................................................................................... 32

MiRealSource, Inc........................................................................................................ 32

RealComp II Ltd. ......................................................................................................... 32

Other ............................................................................................................................. 33

Public Documents/Policy Statements/Conferences................................................... 33

Commission Studies/Guidelines.................................................................................. 33

Advisory Opinions ....................................................................................................... 35

Advocacy Filings .......................................................................................................... 36

Workshops/Hearings/Conferences ............................................................................. 43

Intellectual Property and Patent Law........................................................................ 45

Other ............................................................................................................................. 46

International Activities .............................................................................47

Competition Speeches ...............................................................................48

Statistics .....................................................................................................57

Fiscal Year 2007 (October 1, 2006 though March 31, 2007).................................... 57

Fiscal Year 2006 ........................................................................................................... 58

Fiscal Year 2005 ........................................................................................................... 59

Fiscal Year 2004 ........................................................................................................... 60

Fiscal Year 2003 ........................................................................................................... 62

iv

ABA ANTITRUST SECTION

SPRING MEETING

Bureau of Competition Activity

Fiscal Year 2003 through March 31, 2007

Fiscal

Year

Total

Enforcement

Actions

Consents

Complaints

Merger

Non

Merger

Merger and

Non Merger

Preliminary

and/or

Permanent

Injunctions

Civil Penalty

Cases

Abandoned or

Fix-it-First

Transactions

2003

44

7

16

8

3

0

10

2004

26

10

7

2

2

2

3

2005

20

9

4

0

1

2

4

2006

22

9

5

0

1

0

7

20

9

7

3

0

0

1

2007

(Oct-Mar)

I.

Mergers

A.

Consent Orders

American Air Liquide, Inc.

(Final Order June 29, 2004): L’Air Liquide was permitted to acquire Messer Griesheim GmbH, a

leading industrial gas producer. Under terms of the order, Air Liquide is required to divest six

air separation units operated by Messer in California, Texas, Louisiana, and Mississippi within

six months. According to the complaint, the transaction as proposed would substantially lessen

competition in the market for liquid argon, liquid oxygen and liquid nitrogen.

1

Allergan, Inc.

(Final Order April 21, 2006): The consent order requires that Allergan and Inamed divest the

rights to develop and distribute Reloxin, a potential Botox rival, to settle charges that Allergan’s

$3.2 billion purchase of Inamed would reduce competition and force consumers to pay higher

prices for botulinum toxin type A products. Under the terms of the FTC settlement, the

companies will return the development and distribution rights to Reloxin to Ipsen Ltd., its U.K.based manufacturer.

Aspen Technology, Inc.

(Final Order December 20, 2004) Under terms of a consent order, Aspen agreed to divest

Hypotech’s continuous process and batch process assets and Aspen’s operator training software

and service business to a Commission-approved buyer to settle charges in the complaint and

resolve the administrative proceedings. The Commission issued an administrative complaint on

August 6, 2003 that challenged Aspen’s 2002 acquisition of Hyprotech, Ltd. alleging that the

acquisition eliminated a significant competitor in the provision of process engineering simulation

software for industry. According to the complaint, the acquisition has led to reduced innovation

competition in six specific process engineering simulation software markets.

Baxter International, Inc.

(Final Order February 3, 2003): Baxter settled Commission concerns stemming from its $316

million proposed acquisition of Wyeth Corporation’s generic injectable drug business and agreed

to divest several pharmaceutical products. The Commission charged that the acquisition would

reduce competition in the manufacture and sale of propofol (a general anesthetic); new injectable

iron replacement therapies; metoclopramide (used to treat nausea); and vecuronium and

pancuronium (neuromuscular blocking agents used to temporarily freeze muscles during

surgery). The consent order requires divestitures in each of the pharmaceutical markets.

Barr Pharmaceutical, Inc.

(Final Order December 8, 2006): The consent order settles charges that Barr Pharmaceutical,

Inc.’s proposed acquisition of Pliva d.d for approximately $2.5 billion would have eliminated

current or future competition between Barr and Pliva in certain markets for generic

pharmaceuticals treating depression, high blood pressure and ruptured blood vessels, and in the

market for organ preservation solutions, thereby increasing the likelihood that consumers would

pay more for these vital products. In settling the Commission’s charges, Barr is required to sell

its generic antidepressant trazodone and its generic blood pressure medication

triamterene/HCTZ. Barr also is required to divest either Pliva’s or Barr’s generic nimodipine for

use in treating ruptured blood vessels in the brain. Finally, Barr is required to divest Pliva’s

branded organ preservation solution Custodial.

Buckeye Partners, L.P.

(Final Order December 17, 2004): Buckeye agreed to notify the Commission before acquiring

any interest in the Niles petroleum terminal for a period of ten years under provisions of a

consent order. The consent order settled charges that Buckeye's proposed acquisition of five

refined petroleum products pipelines and 24 petroleum products terminals in the United States

2

from Shell Oil Company would reduce competition in the market for the terminaling of gasoline,

diesel fuel, and other light petroleum products in the area of Niles, Michigan.

Boston Scientific Corp

(Final Order July 25, 2006): The consent order settles chargers that the $27 billion acquisition of

Guidant Corporation by Boston Scientific Corporation would harm competition and consumers

in several significant medical device markets. Guidant Corporation by Boston Scientific

Corporation are the largest market shareholders in several coronary medical device markets in

the U.S., together accounting for 90% of the U.S. PTCA balloon catheter market and 85% of the

U.S. coronary guidewire market. The consent order required the divestiture of Guidant’s

vascular business to an FTC-approved buyer.

Cemex, S.A.

(Final Order March 25, 2005): Cemex S.A. agreed to settle concerns stemming from its proposed

$5.8 billion acquisition of RMC Group PLC. The final consent order required Cemex to divest

RMC’s five ready-mix concrete plants in the Tucson, Arizona area, at no minimum price to a

Commission-approved buyer.

Cephalon, Inc.

(Final Order September 20, 2004): The consent order settled charges that Cephalon's proposed

acquisition of Cima Labs, Inc. would allow Cephalon to continue its monopoly in the United

States market for drugs that eliminate or reduce the spikes of severe pain that chronic cancer

patients experience. The consent order required Cephalon to grant Barr Laboratories, Inc. a fully

paid, irrevocable license to make and sell a generic version of Cephalon's breakthrough cancer

pain drug, Actiq, in the United States.

Chevron Texaco Corporation

(Final Order July 27, 2005): Under the terms of the consent orders Chevron and Unocal will

cease enforcing Unocal’s patents covering reformulated gasoline that complies with California

Air resources Board Standard, will not undertake any new enforcement efforts related to the

particular patents, and will cease all attempts to collect damages, royalties, or other payments

related to the use of any of the patents. In addition, the companies will dismiss all pending legal

actions related to alleged infringement of the patents. According to the complaint, the

acquisition of the Unocal patents by Chevron would have facilitated coordinated interaction

among downstream refiners and marketers of CARB gasoline.

Cytec Industries, Inc.

(Final Order April 7, 2005): A final consent order requires Cytec Industries, Inc. to divest UCB’s

Amino Resins Business in Massachusetts and Germany to a Commission-approved buyer.

According to the complaint issued with the agreement, the acquisition as proposed would

eliminate direct competition between the two firms in the market for amino resins used for

industrial liquid coatings and rubber adhesion promotion.

Dainippon Ink and Chemicals, Inc.

(Final Order March 13, 2003): Dainippon agreed to divest the perylene business of its U.S.

subsidiary, Sun Chemical Corporation, to Ciba Specialty Chemicals Inc. and Ciba Specialty

3

Chemicals Corporation to settle allegations that its proposed acquisition of Bayer Corporation’s

high-performance pigment manufacturing facility would eliminate competition in the highly

concentrated world market for perylenes – organic pigments used to impart unique shades of red

color to products, including coatings, plastics and fibers.

DaVita Inc.

(Final Order November 18, 2005): The consent order resolves the competitive issues raised by

DaVita’s proposed $3.1 billion purchase of rival outpatient dialysis clinic operator Gambro

Healthcare Inc. from Gambro AB. Pursuant to the order, DaVita sold 69 dialysis clinics and end

two management services contracts in 35 markets across the United States within 10 days of

consummating its purchase of Gambro. The Commission has approved Renal Advantage Inc. as

the buyer of most of the clinics to be divested, and entered into an order to maintain assets with

DaVita.

DSM N.V.

(Final Order January 6, 2004): A consent order permitted DSM N.V. to acquire the Vitamins and

Fine Chemicals Division of Roche Holding AG but requires DSM to divest its phytase business

to BASF AG within 10 days after the transaction is completed. Phytase is an enzyme added to

certain animal feed to promote the digestion of nutrients necessary for livestock production.

Enterprise Products Partners L.P.

(Final Order November 23, 2004): Enterprise Products Partners L.P. settled charges that its $13

billion merger with GulfTerra Energy/Partners L.P. would eliminate competition in two markets:

the pipeline transportation of natural gas from the West Central Deepwater region of the Gulf of

Mexico; and propane storage and terminaling services in Hattisburg, Mississippi. The consent

order requires the divestiture of an interest in a pipeline transportation system and an interest in a

propane facility that serves the Dixie Pipeline.

Enterprise Products Partners L.P.

(Final Order November 3, 2006): Enterprise Products Partners L.P. settled charges that its $1.1

billion acquisition of TEPPCO Partners’ NGLs salt dome storage businesses would likely result

in higher prices and service degradations by reducing the number of commercial salt dome NGL

storage providers in Mont Belvieu, Texas, from four to three. The FTC’s order required

TEPPCO to divest its interests in the world’s largest NGL storage facility in Mont Belvieu,

Texas, to an FTC-approved buyer.

Fresenius AG

(Final Order July 6, 2006): Fresenius AG settled charges that its purchase of rival dialysis

provider Renal Care Group, Inc. would likely have resulted in higher prices for dialysis services.

The consent order requires that Fresenius AG will sell 91 outpatient kidney dialysis clinics and

financial interests in 12 more.

GenCorp Inc.

(Final Order December 19, 2003): A consent order allowed GenCorp Inc. to acquire Atlantic

Research Corporation while requiring the divestiture of Atlantic’s in-space liquid propulsion

business within six months of consummating the transaction. According to the complaint issued

4

with the consent order, the transaction as originally planned would have lessened competition in

the United States in four different types of in-space propulsion engines: monopropellant

thrusters; bipropellant apogee thrusters; dual mode apogee thrusters; and biopropellant attitude

control thrusters.

General Dynamics Corporation

(Final Order February 9, 2007): The consent order settled charges that General Dynamics’

proposed $275 million acquisition of SNC Technologies, Inc. and SNC Technologies, Corp.

(collectively, SNC) would likely undermine competition by bringing together two of only three

competitors providing the U.S. military with melt-pour load, assemble, and pack (LAP) services

used during the manufacture of ammunition for mortars and artillery. Absent relief, the proposed

acquisition would likely force the U.S. military to pay higher prices for these munitions. General

Dynamics is required to sell its interest in American Ordnance to an FTC-approved buyer within

four months of acquiring SNC.

General Electric Company

(Final Order January 28, 2004): A final consent order settled antitrust concerns stemming from

General Electric Company’s proposed acquisition of Agfa-Gevaert N.V.’s nondestructive testing

business. According to the complaint issued with the consent order, the transaction as proposed

would have eliminated competition in the United States markets for portable flaw detectors,

corrosion thickness gages, and precision thickness gages - equipment used to inspect the

tolerance of materials without damaging them or impairing their future usefulness. The consent

order requires General Electric to divest its worldwide Panametrics Ultrasonic NDT business to

R/D Tech, Inc. within 20 days after the transaction is completed.

General Electric Company

(Final Order October 25, 2004): General Electric was permitted to acquire InVision

Technologies, Inc. with conditions that it divest InVision's YXLON x-ray nondestructive testing

and inspection equipment to a Commission approved acquirer. According to the complaint

issued with the consent order, the two firms are direct competitors in a highly concentrated

market. The consent order protects competition in the United States market for specialized x-ray

testing and inspection including standard x-ray cabinets; x-ray systems equipped with automated

defect recognition software; and high-energy x-ray generators.

Genzyme Corporation

(Final Order January 31, 2005): A consent order allowed Genzyme’s acquisition of ILEX

Oncology, Inc., but requires the companies to divest certain assets in the market for solid organ

transplant acute therapy drugs. Specifically, Genzyme is required to divest all contractual rights

related to ILEX’s Campath®, an immunosuppressant antibody used in solid organ transplants to

Schering AG.

Hologic, Inc.

(Final Order August 9, 2006): The Commission approved a final consent order to ensure the

maintenance of competition in the market for prone stereotactic breast biopsy systems (SBBSs).

The Commission had challenged this merger which was consummated in 2005. The order

5

required the divestiture of all prone SBBS assets to Siemens, a company well-positioned to

become a competitor in this market.

Hospira, Inc.

(Final Order March 23 18, 2007): The consent order settles charges that Hospira Inc.’s proposed

$2 billion acquisition of rival drug manufacturer Mayne Pharma Ltd. Would likely reduce

competition and harm consumers. In settling the Commission’s charges, the companies have

agreed to divest to Barr Pharmaceuticals, Inc. (Barr), within 10 days of the acquisition, Mayne’s

rights and assets related to the following products: hydromorphone hydrochloride

(hydromorphone), nalbuphine hydrochloride (nalbuphine), morphine sulfate (morphine),

preservative-free morphine, and deferoxamine mesylate (deferoxamine).

Itron, Inc.

(Final Order August 5, 2004): The consent order, designed to preserve competition in the market

for the manufacture and sale of mobile radio frequency automatic meter reading technologies for

electric utilities in the United States, permitted Itron's $255 million acquisition of Schlumberger

Electricity, Inc. The consent order requires Itron to grant a royalty-free, perpetual, and

irrevocable license to Hunt Technologies, Inc., creating an effective competitor in this market

that allows utility companies and others to gather electric consumption data automatically and

remotely from electricity meters.

Johnson & Johnson

(Final Order December 12, 2005): The consent order protects competition in three medical

device product markets affected by Johnson & Johnson’s proposed $25.4 billion acquisition of

Guidant Corporation. Under the terms of the order, J&J is required to 1) grant to a third party a

fully paid-up, non-exclusive, irrevocable license, enabling that third party to make and sell drug

eluting stents with the Rapid Exchange delivery system, 2) divest to a third party J&J’s

endoscopic vessel harvesting product line, and 3) end its agreement to distribute Novare Surgical

System, Inc.’s proximal anastomotic assist device. On May 31st, 2006 the Commission granted

a petition filed by Johnson and Johnson Corporation, requesting that the FTC reopen and set

aside the entire decision and order concerning the proposed acquisition of Guidant Corporation.

Johnson & Johnson

(Final Order January 19, 2007): The consent order settles charges that Johnson & Johnson’s

(J&J) proposed $16.6 billion acquisition of Pfizer Inc.’s (Pfizer) Consumer Healthcare business

would likely reduce competition in the U.S. markets for over-the-counter (OTC) H-2 blockers

used to prevent and relieve heartburn, OTC hydrocortisone anti-itch products, OTC night-time

sleep aids, and OTC diaper rash treatments. In settling the Commission’s charges, the

companies have agreed to sell Pfizer’s Zantac H-2 blocker business to Boehringer Ingelheim

Pharmaceuticals Inc. (Boehringer), and Pfizer’s Cortizone hydrocortisone anti-itch business,

Pfizer’s Unisom night-time sleep aid business, and J&J’s Balmex diaper rash treatment business

to Chattem, Inc.

Kinder Morgan, Inc.

(Final Order March 16, 2007): The order settles charges that the proposed $22 billion deal

whereby energy transportation, storage, and distribution firm Kinder Morgan, Inc. (KMI) would

6

be taken private by KMI management and a group of investment firms, including private equity

funds managed and controlled by The Carlyle Group (Carlyle) and Riverstone Holdings LLC

(Riverstone) would threaten competition between KMI and Magellan in eleven metropolitan

areas in the Southeast, likely resulting in higher prices for gasoline and other light petroleum

products. The order requires that Carlyle’s and Riverstone’s interest in Magellan become a

passive investment, by requiring them to: (1) removing all of their representatives from the

Magellan Board of Managers and its boards of directors, (2) ceding control of Magellan to its

other principal investor, Madison Dearborn Partners, and (3) not influencing or attempting to

influence the management or operation of Magellan.

Libbey, Inc.

(Final Order October 7, 2002): The Commission authorized staff to seek a preliminary injunction

to block Libbey’s proposed $332 million acquisition of Anchor Hocking, a subsidiary of Newell

Rubbermaid, Inc., on grounds that the acquisition would substantially lessen competition in the

market for soda-lime glassware sold to the food service industry in the United States. A

complaint was filed in the U.S. District Court for the District of Columbia on January 14, 2002.

The district court granted the Commission’s request for an injunction on April 22, 2002. An

administrative complaint, issued on May 9, extend the injunction until the conclusion of the

administrative proceedings. Pursuant to the delegation of authority, the Commission withdrew

the matter from adjudication on July 25, 2002, to consider a proposed consent agreement. A

consent order was finalized October 7, 2002.

Linde, AG

(Final Order September 5, 2006): In August 2006, the FTC approved a final consent order

relating to the proposed $14.4 billion acquisition of the BOC Group by Linde requiring Linde to

divest Air Separation Units (ASUs), bulk refined helium assets, and other assets in eight

localities across the United States. The consent order aims to maintain competition in the

markets for liquid oxygen, liquid helium, and bulk refined helium in several U.S. markets.

Magellan Midstream Partners, L.P.

(Final Order November 23, 2004): Under terms of a consent order, Magellan completed its

acquisition of pipelines and terminals in the Midwestern United States and a refined petroleum

products terminal in Oklahoma City that supplies light petroleum products such as gasoline and

diesel fuel from the Shell Oil Company. The consent order required Magellan to divest the

Shell Oklahoma City terminal to a Commission-approved buyer within six months after the

transaction is consummated.

MSC. Software Corporation

(Final Order October 29, 2002): MSC settled charges that its 1999 acquisitions of Universal

Analytics, Inc. and Computerized Structural Analysis & Research Corp. eliminated competition

between the three firms in the development and application of engineering software. The

administrative complaint issued October 2000, alleged that the two acquisitions would eliminate

competition for advanced versions of Nastran, an engineering simulation software program used

throughout the aerospace and automotive industries. The consent order required MSC to divest

at least one clone copy of its current advance Nastran through royalty-free perpetual, nonexclusive licenses to one or two acquirers approved by the Commission.

7

Novartis AG

(Final Order September, 21 2005): To resolve overlaps for three generic pharmaceuticals that

arose from Novartis AG’s acquisition of Eon Labs, Inc., under the terms of a consent order,

Novartis is required to divest all the assets necessary to manufacture and market generic

desipramine hydrochloride tablets, orphenadrine citrate extended release (ER) tablets, and

rifampin oral capsules in the United States to Amide within 10 days of Novartis’s acquisition of

Eon. Further, Novartis, through its Sandoz generic pharmaceuticals division, will supply Amide

with orphenadrine citrate ER and desipramide hydrochloride tablets until Amide obtains Food

and Drug Administration (FDA) approval to manufacture the products itself, and will assist

Amide in obtaining all necessary FDA approvals.

Occidental Chemical Corporation

(Final Order July 13, 2005): A consent order allows Occidental Chemical Company’s purchase

of the chemical assets of Vulcan Materials Company, provided Occidental divests Vulcan’s Port

Edwards, Wisconsin, chemical facility and related assets. The consent order alleviates the

alleged anticompetitive impact of the acquisition in the markets for potassium hydroxide,

anhydrous potassium carbonate (APC), and potassium carbonate, which includes APC and liquid

potassium carbonate. The Port Edwards facility will be divested to ERCO Worldwide or to

another Commission-approved buyer within six months if a problem is encountered with ERCO

sale.

Penn National Gaming, Inc.

(Final Order September 15, 2005): A consent order permitted Penn National Gaming, Inc.’s

acquisition of Argosy Gaming Company, provided Penn sells Argosy’s Baton Rouge casino to

Columbia Sussex Corporation within four months of the order becoming final.

Pfizer Inc.

(Final Order May 27, 2003): A final consent order permits Pfizer Inc.’s acquisition of Pharmacia

Corporation while requiring the divestiture of various products including extended release drugs

used in the treatment of an overactive bladder; hormone replacement therapies; erectile

dysfunction; canine arthritis; and motion sickness. Novartis AG, Neurocrine Biosciences, Inc.,

Schering-Plough Corporation, Johnson & Johnson, Insight Pharmaceuticals Corporation, and

Cadbury Schweppes are named in the order as potential buyers of the various pharmaceuticals

and products.

Phillips Petroleum Company

(Final Order February 7, 2003): A final consent order allows the merger of Phillips Petroleum

and Conoco Inc. but requires certain divestitures and other relief to maintain competition in the

gasoline refining market in specific areas of the United States. Among the assets to be divested

are refineries, propane terminals, and natural gas gathering facilities. The combined firm will be

known as ConocoPhillips.

Quest Diagnostics, Inc.

(Final Order April 3, 2003): Quest Diagnostics settled antitrust concerns that its proposed

acquisition of Unilab Corporation would substantially increase concentration in the clinical

8

laboratory testing services market by agreeing to divest clinical laboratory testing assets in

Northern California to Laboratory Corporation of America.

Sanofi-Synthélabo

(Final Order September 20, 2004): The consent order settled antitrust concerns that Sanofi's

proposed $64 billion acquisition of Aventis would create significant overlaps in several markets

for pharmaceutical products while creating the world's third largest pharmaceutical company.

Under terms of the consent order, Sanofi must: 1) divest its Arixtra factor Xa inhibitor to

GlaxoSmithKline, plc; 2) divest its key clinical studies for the Campto® cytotoxic colorectal

cancer treatment to Pfizer, Inc. and 3) divest Aventis' contractual rights to the Estorra insomnia

drug either to Sepracor, Inc. or to another Commission-approved buyer.

Service Corporation International

(Final Order January 5, 2007): The consent order settled charges that Service Corporation

International’s (SCI) proposed acquisition of Alderwoods Group Inc. would likely lessen

competition in 47 markets for funeral or cemetery services, leaving consumers with fewer

choices and the prospect of higher prices or reduced levels of service. Under the settlement, SCI

must sell funeral homes in 29 markets and cemeteries in 12 markets across the United States. In

six other markets, SCI must sell certain funeral homes that it plans to acquire or end its licensing

agreements with third-party funeral homes affiliated with SCI.

Shell Oil Company

(Final Order November 18, 2002): Shell Oil Company was allowed to complete its $1.8 billion

acquisition of Pennzoil-Quaker State Company but required to divest certain assets to maintain

healthy competition in the refining and marketing of Group II paraffinic base oil in the United

States and Canada. Under terms of the consent order, Shell and Pennzoil must divest its 50

percent interest in Excel Paralubes (a base oil refinery in Westlake, Louisiana) and freeze

Pennzoil’s right to obtain additional Group II supply under a contract with ExxonMobil at

approximately current levels (up to 6,500 barrels of base oil per day).

Southern Union Company

(Final Order July 16, 2003): Southern Union Company settled antitrust concerns stemming from

its proposed acquisition of the Panhandle pipeline from CMS Energy Corporation. The consent

order permitted the acquisition but required Southern Union to terminate an agreement to

manage the Central pipeline which transports natural gas to several counties in Missouri and

Kansas.

Teva Pharmaceutical Industries Ltd

(Final Order March 7, 2006): The consent order allowed Teva to acquire IVAX Corporation,

provided the companies sell the rights and assets needed to manufacture and market 15 generic

pharmaceutical products. Among the drugs sold were several forms of generic amoxicillin and

amoxicillin clavulanate potassium that are widely used in the United States.

The Procter & Gamble Company

(Final Order December 16, 2005): The consent order permitted The Procter & Gamble

Company’s acquisition of rival consumer products manufacturer The Gillette Company,

9

provided the companies divest: 1) Gillette’s Rembrandt at-home teeth whitening business; 2)

P&G’s Crest SpinBrush battery-powered and rechargeable toothbrush business; and 3) Gillette’s

Right Guard men’s antiperspirant deodorant business. In addition, P&G must amend its joint

venture agreement with Philips Oral Health Care, Inc. regarding the Crest Sonicare IntelliClean

System rechargeable toothbrush to allow Philips to independently market and sell rechargeable

toothbrushes.

The Boeing Company

(Proposed Consent Agreement Accepted for Public Comment on October 3, 2006): The

Commission intervened in the formation of United Launch Alliance (ULA), a proposed joint

venture between the Boeing Corp. and Lockheed Martin Corp. The FTC’s complaint alleged

that the formation of ULA as originally structured would have reduced competition in the

markets for U.S. government medium to heavy launch services and space vehicles. In settling

the Commissions’ charges, the parties agreed to take certain actions (such as nondiscrimination

requirements and firewalls) to address ancillary competitive harms not inextricably tied to the

national security benefits of ULA.

Thermo Electron Corporation

(Final Order December 5, 2006): The consent order settled charges that charged that Thermo

Electron Corporation’s proposed $12.8 billion acquisition of Fisher Scientific International, Inc.

would harm competition in the U.S. market for high-performance centrifugal vacuum

evaporators (CVEs) in violation of the antitrust laws. Thermo and Fisher are the only two

significant suppliers of high-performance CVEs in the United States and the proposed

transaction would eliminate the direct price, service, and innovation competition that exists

between them. To settle the Commission’s charges, Thermo is required to divest Fisher’s

Genevac division, which includes Fisher’s entire CVE business, within five months of the date

the consent agreement was signed.

Valero L.P.

(Final Order July 27, 2005): The consent order permitted Valero L.P. to acquire Kaneb Services

LLC and Kaneb Pipe Line Partners subject to the divestitures of assets that will preserve existing

competition for petroleum transportation and terminaling in Northern California, Pennsylvania,

and Colorado, and avoid a potential increase in bulk gasoline and diesel prices. The order also

requires Valero to develop an information firewall and maintain open, non-discriminatory access

to two retained Northern California terminals, in order to ensure access to ethanol terminaling in

Northern California.

Wal-Mart Stores, Inc.

(Final Order February 27, 2003): A consent order settled Commission concerns that Wal-Mart’s

proposed acquisition of the largest supermarket chain in Puerto Rico, Supermercados Amigo,

Inc., would eliminate competition between supercenters and club stores owned or controlled by

Wal-Mart and supermarkets owned or controlled by Amigo. While the consent order permits the

acquisition, it requires Wal-Mart to divest four Amigo supermarkets in Cidra, Ponce, Manati,

and Vega Baja, Puerto Rico to Supermercados Maximo.

10

Watson Pharmaceuticals, Inc.

(Final Order December 12, 2006): A consent order settled charges that Watson Pharmaceuticals,

Inc.’s proposed $1.9 billion acquisition of Andrx Corporation, would have likely led to

competitive problems in the markets for 13 generic drug products. Watson was required to end

its marketing agreements with Interpham Holdings, divest Andrx’s right to develop, make, and

market generic extended release tablets that correct the effects of type 2 diabetes, and divest

Andrx’s rights and assets related to the developing and marketing of 11 generic oral

contraceptives.

B.

Authorizations to Seek Preliminary Injunctions

Aloha Petroleum, Ltd

(July 26, 2005): The Commission authorized staff, in conjunction with the Hawaii Attorney

General, to seek a preliminary injunction to block Aloha Petroleum’s proposed acquisition of

Trustreet Properties. Aloha sought to acquire Trustreet’s half interest in the Barber Point

petroleum importing terminal, when Aloha already owned the other half interest. The proposed

acquisition would have reduced the number of marketers with ownership or access to a refinery

or importing terminal from five to four, and the number of suppliers selling to unintegrated

retailers from three to two. After Aloha subsequently announced a long-term agreement with a

third party, Mid-Pac Petroleum that would enable Mid-Pac to replace Trustreet as a bulk gasoline

supplier, the Commission sought to dismiss its federal court complaint on the ground of changed

circumstances.

Arch Coal, Inc.

(March 30, 2004): The Commission authorized staff to file a complaint to block Arch Coal,

Inc.’s proposed acquisition of Triton Coal Company, L.L.C. from New Vulcan Holdings, L.L.C.

on grounds that the acquisition would increase concentration and tend to create a monopoly in

the market for coal mined from the Southern Powder River Basin and in the production of 8800

British Thermal Unit coal. On April 1, 2004, the complaint was filed in the U.S. District Court

for the District of Columbia. On June 13, 2005 the Commission announced that it was closing

its investigation, saying that it will not continue with administrative litigation challenging the

deal.

Kroger Company/Raley’s Corporation

(October 2, 2002): The preliminary injunction authorized by the Commission during the

investigation into Kroger’s acquisition of 18 Raley’s supermarkets in the Las Vegas, Nevada

area was not filed. After staff determined that the transaction would promote healthy

competition in the Las Vegas/Henderson area due to the rapid growth of the market and the

presence of Wal-Mart, Albertson’s, Kroger and Safeway - the four major competitors in the area,

the investigation was closed.

Nestlé Holdings, Inc.

(March 4, 2003): The Commission authorized staff to seek a preliminary injunction to block the

merger of Nestlé and Dreyer’s Grand Ice Cream, Inc. on grounds that the merger would reduce

competition in the highly concentrated market for superpremium ice cream. Nestlé markets

11

superpremium ice cream under the Häagen Dazs brand; Dreyer’s superpremium brands include

Dreamery, Godiva and Starbucks. Before the complaint was filed in a federal district court, the

parties agreed to enter into a consent agreement to settle the charges. The final order requires the

divestiture of superpremium ice cream brands Dreamery and Godiva, the Whole Fruit sorbet

brand, and Nestlé’s distribution assets to CoolBrands International, Inc.

Vlasic Pickle Company

(October 22, 2002): The Commission authorized staff to seek a preliminary injunction to block

the proposed acquisition of Claussen Pickle Company by Hicks, Muse, Tate & Furst Equity Fund

V L.P., the owner of Vlasic Pickle Company on grounds that the transaction would combine the

dominant firm in the market for refrigerated pickles (Claussen) with its most significant

competitor in refrigerated pickles (Vlasic). Six days after the complaint was filed in federal

district court, the parties abandoned the transaction.

C.

Commission Opinions/Initial Decisions

Chicago Bridge & Iron Company

(January 7, 2005): The Commission upheld in part the ruling of an administrative law judge that

Chicago Bridge & Iron’s acquisition of the Water Division and the Engineered Construction

Division of Pitt-Des Moines, Inc. created a near-monopoly in four separate markets involving the

design and construction of various types of field-erected specialty industrial storage tanks in the

United States. In an effort to restore competition as it existed prior to the merger, the

Commission ordered Chicago Bridge to reorganize the relevant product business into two

separate, stand-alone, viable entities capable of competing in the markets described in the

complaint and to divest one of those entities within six months.

With an administrative complaint issued on October 25, 2001, the Commission

challenged the February 2001 purchase of the Water Division and Engineered Construction

Division of Pitt-Des Moines, Inc. alleging that the acquisition significantly reduced competition

in four separate markets involving the design and construction of various types of field-erected

specialty industrial storage tanks in the United States. The initial decision filed June 27, 2003

upheld the complaint.

On June 27, 2004, an administrative law judge upheld the complaint and ordered the

divestiture all of the assets acquired in the acquisition. In December 2004, the Commission

approved an interim consent order prohibiting Chicago Bridge & Iron from altering the assets

acquired from Pitt-Des Moines, Inc. except “in the ordinary course of business.” These assets

included but were not limited to real property; personal property; equipment; inventories; and

intellectual property.

Northwestern Healthcare Corporation

(October 17, 2005): In an Initial Decision the Administrative law judge found that Evanston

Northwest Healthcare Corporation’s acquisition of an important competitor, Highland Park

Hospital, resulted in higher prices and substantially lessened competition for acute care inpatient

services in parts of Chicago’s northwestern suburbs. The Administrative law judge found that

the evidence established that the merged hospital exercised its enhanced post-merger market

power to obtain price increases significantly above its premerger prices and substantially larger

12

than price increases obtained by comparable hospitals. The ALJ also found that the evidence

ruled out explanations for the price increase, other that the exercise of market power. The ALJ

entered an order that would require the divestiture of the acquired hospital.

The hospital’s appeal of the ALJ’s decision and order requiring divestiture of Highland Park

Hospital is now pending before the Commission.

On February 10, 2004 the Commission issued an administrative complaint alleging that

following Evanston Northwestern Healthcare Corporations’s acquisition of Highland Park

Hospital prices charged to health insurers for medical services increased and, therefore, higher

costs for health insurance were passed on to consumers of hospital services in the Cook and Lake

counties of Illinois. The complaint also alleges that a physicians group affiliated with both

hospitals, Highland Park Independent Physician Group, negotiated prices for physicians on staff

at Evanston as well as for several hundred independent physicians not affiliated with either

hospital. According to the complaint, these actions constitute illegal price fixing among

competing physicians or physician groups and deny consumers the benefits of competition in

physician services.

In May, 2005, the Commission approved a final consent order to resolve a separate count

in the complaint involving alleged price fixing by doctors associated with the two hospitals.

D.

Court Decisions

Arch Coal, Inc.

(August 13, 2004): The U.S. District Court for the District of Columbia denied the

Commission’s request for a preliminary injunction to block Arch Coal, Inc.’s proposed

acquisition of Triton Coal Company, L.L.C. from new Vulcan Holdings, L.L.C. The parties

consummated the deal after the Circuit Court of Appeals for the District of Columbia refused to

issue a stay pending an appeal of the district court decision.

The administrative complaint issued on April 6, 2004 challenged the proposed acquisition

of all the assets of Triton Coal Company, L.L.C. from New Vulcan Coal Holdings, L.L.C.

According to the complaint, the acquisition would have combined two of the four leading

producers of coal in Wyoming’s Southern Powder River Basin. On September 10, 2004, the

administrative complaint was withdrawn from adjudication. The Commission decided not to

pursue an appeal of the decision of the U.S. District Court for a preliminary injunction to block

the sale of Triton to Arch Coal. On June 13, 2005 the Commission announced that it was closing

its investigation, saying that it will not continue with administrative litigation challenging the

deal.

E.

Order Violations

Boston Scientific Corporation

(March 31, 2003): A federal district judge ordered Boston Scientific Corporation to pay

$7,040,000 in civil penalties to settle charges that it violated a 1995 consent order when it failed

to provide Hewlett-Packard Company with a license to all of its intellectual property and

technical information relating to intravascular ultrasound catheters. The complaint was filed on

13

October 31, 2000 by the Department of Justice on behalf of the Commission. The trial was held

in August 2002.

RHI AG

(April 1, 2004): RHI AG paid a total civil penalty of $755,686.41 to settle charges that it violated

a 1999 consent order concerning its acquisition of Global Industrial Technologies, Inc.

According to the complaint, filed in the United States District Court for the District of Columbia,

RHI not only failed to divest the two refractories plants and other assets to Resco Products, Inc.,

but it did not completely comply with other provisions required by the settlement agreement.

F.

Other Commission Orders

None

G.

Administrative Complaints

Equitable Resources, Inc.

(March 15, 2007): The Commission authorized staff to file an administrative complaint

challenging Equitable Resources, Inc.’s (Equitable) proposed acquisition of The Peoples Natural

Gas Company (Dominion Peoples). Equitable and Dominion Peoples are each other’s sole

competitors in the distribution of natural gas to nonresidential customers in certain areas of

Allegheny County, Pennsylvania, which includes Pittsburgh. The complaint alleges that the

proposed transaction would result in a monopoly for many customers that now enjoy

competition.

H.

Other

Horizontal Merger Investigation Data

Fiscal Years 1996 – 2005. Staff analysis of horizontal investigations. The staff tabulated certain

market structure information as it relates to the Commission’s decision whether or not to seek

relief in specific markets investigated. Released January 25, 2007.

2006 Report on Ethanol Market Concentration

The study examines the current state of ethanol production in the United States and measures

market concentration using capacity and production data. Released December 5, 2006.

2005 Report on Ethanol Market Concentration

The study examines the current state of ethanol production in the United States and measures

market concentration using capacity and production data. Released December 2, 2005.

14

Reforms to the Merger Review Process

(Effective February 17, 2006): Reforms to the agency’s merger review process establishing that

the FTC will:

• limit the number of employees required to provide information in response to a second

request, provided the party complies with specified conditions;

• reduce the time period for which a party must provide documents in response to the

second request;

• allow a party to preserve far fewer backup tapes and produce documents on those tapes

only when responsive documents are not available through more accessible sources; and

• significantly reduce the amount of information parties must submit regarding documents

they consider to be privileged.

Conference on the Price Effects of Mergers and Concentration in the United States

Petroleum Industry

(January 14, 2005, Washington, DC.) The conference reviewed two studies that examined price

effects within the petroleum industry: the March 2004 case study of the effects of the

Marathon/Ashland Corporation joint venture; the second, the May 2004 report by the

Government Accountability Office that examined the effects of mergers and market

concentration in the United States petroleum industry.

Horizontal Merger Investigation Data

Fiscal Years 1996 – 2003. Staff analysis of horizontal investigations. The staff tabulated certain

market structure information as it relates to the Commission’s decision whether or not to seek

relief in specific markets investigated. Released February 2004.

Merger Efficiency Roundtable

(December 9 - 10, 2002; Washington, DC): Experts in mergers and acquisitions from the

academic, consulting, and business communities gave presentations on how to determine

whether a proposed transaction is likely to generate merger efficiencies.

Merger Enforcement Workshop

(February 17 - 19, 2004) sponsored by the Federal Trade Commission and the Department of

Justice. Topics discussed:

• Hypothetical Monopolist Test

• Concentration & Market Shares

• Monopsony

• Non-Price Competition/Innovation

• Unilateral Effects

• Coordinated Effects

• Uncommitted Entry

• Efficiencies/Dynamic Analysis/Integrated Analysis

Merger Remedies - Second Workshop

(October 23, 2002; New York, New York): Workshop, co-hosted by the Antitrust and Trade

Regulation Committee of The Association of the Bar of the City of New York, was designed to

15

gather information from a broad range of interested parties regarding consent order remedies in

merger and acquisition matters.

II. Hart-Scott-Rodino Antitrust Improvements Act

Enforcement

A.

Court Decisions

Scott R. Sacane

(September 26, 2005): A Connecticut-based hedge fund manager who failed to report several

large stock purchases before they were made, as required by the Hart-Scott-Rodino (HSR)

Premerger Notification Act, paid a $350,000 civil penalty to settle Federal Trade Commission

charges. The complaint alleged that Scott Sacane, manager of the Durus Life Sciences Master

Fund, failed to make four required premerger notification filings. His failure to do so violated the

HSR Act for each transaction.

William H. Gates, III

(May 4, 2004): William H. Gates, III paid $800,000 in civil penalties to settle charges that he

acquired more than ten percent of the voting securities of Republic Services, Inc. without

observing the filing and waiting period requirements under the Hart-Scott-Rodino Antitrust

Improvements Act of 1976. The complaint was filed in the federal district court in Washington,

DC.

B.

Consent Orders

None

C.

Complaints - Filed

Blockbuster, Inc.

(March 4, 2005): The Commission filed a complaint under Section 7A(g)(2) of the Clayton Act

in U.S. District Court for the District of Columbia to require Blockbuster, Inc. to provide

sufficient and accurate pricing data in compliance with the second request issued by the

Commission under the statutory rules of the Hart-Scott-Rodino Act. Blockbuster cannot proceed

with its proposed acquisition of Hollywood Entertainment Corporation until 30 days from the

date it has substantially complied with the second request.

16

D.

Complaints - Authorized

Arch Coal, Inc.

(February 23, 2004): The Commission authorized staff to file a complaint in federal district court

for a temporary restraining order under Section 7A(g)(2) of the Clayton Act to block Arch Coal’s

proposed acquisition of Triton Coal Company until Arch Coal substantially complied with the

Commission’s request for addition information under the Hart-Scott-Rodino Act. After Arch

Coal was notified that the Commission authorized a Section 7A(g)(2) complaint, Arch withdrew

its Certification of Substantial Compliance with the second request and provided additional

information. On June 13, 2005 the Commission announced that it was closing its investigation,

saying that it will not continue with administrative litigation challenging the deal.

E.

Rules and Formal Interpretations

Hart-Scott Final Rulemaking

(Effective February 21, 2007): The notification and filing thresholds under the premerger rules

have been revised as required by the 2000 amendments to Section 7A of the Clayton Act.

Section 7A(a)(2) requires the Commission to revise the jurisdictional thresholds annually, based

on the change in gross national product, in accordance with section 8(a)(5) for each fiscal year

beginning after September 30, 2004.

Hart-Scott Final Rulemaking

(Effective July 23, 2006): The Federal Trade Commission and the Department of Justice’s

Antitrust Division implemented an electronic filing system that allows merging parties to submit

via the Internet premerger notification filings required by the Hart-Scott-Rodino Act.

Hart-Scott Final Rulemaking

(Effective February 18, 2006): The notification and filing thresholds under the premerger rules

have been revised as required by the 2000 amendments to Section 7A of the Clayton Act.

Section 7A(a)(2) requires the Commission to revise the jurisdictional thresholds annually, based

on the change in gross national product, in accordance with section 8(a)(5) for each fiscal year

beginning after September 30, 2004.

Hart-Scott Rodino Reform / Amended Final Rules

(Effective January 11, 2006): Amendments to Parts 801 and 802 of the Premerger Notification

Rules allowing filing persons to provide an Internet address linking directly to the documents

required by Items 4(a) and (b) in lieu of providing paper copies.

Hart-Scott Rodino Reform / Amended Final Rules

(Effective December 12, 2005): Amendments to Parts 801 and 802 of the Premerger Notification

Rules requiring use of 2002 NAICS rather than 1997 NAICS when reporting economic data by

industry and product codes.

17

Hart-Scott Rodino Final Rulemaking

(Effective April 7, 2005): Final rules adopted from proposed rules published April 8, 2004. The

amendments require notification of acquisitions of interests in unincorporated entities and

formations of unincorporated entities. The rules also extend the application of certain

exemptions, including the intraperson exemption, to unincorporated entities.

Hart-Scott Final Rulemaking

(Effective March 2, 2005): The notification and filing thresholds under the premerger rules have

been revised as required by the 2000 amendments to Section 7A of the Clayton Act. Section

7A(a)(2) requires the Commission to revise the jurisdictional thresholds annually, based on the

change in gross national product, in accordance with section 8(a)(5) for each fiscal year

beginning after September 30, 2004.

F.

Other

Model Retail Second Request

(April 28, 2004) Model Request for Additional Information and Documentary Material (Second

Request) for transactions involving retail industries.

Premerger Notification Annual Report to Congress Pursuant to Section 201 of the HartScott-Rodino Antitrust Improvements Act of 1976

(August 1, 2003): Twenty-fifth Annual Report (Fiscal Year 2002).

Premerger Notification Annual Report to Congress Pursuant to Section 201 of the HartScott-Rodino Antitrust Improvements Act of 1976

(September 7, 2004): Twenty-sixth Annual Report (Fiscal Year 2003).

Premerger Notification Annual Report to Congress Pursuant to Section 201 of the HartScott-Rodino Antitrust Improvements Act of 1976

(August 16, 2005): Twenty-seventh Annual Report (Fiscal Year 2004).

Premerger Notification Annual Report to Congress Pursuant to Section 201 of the HartScott-Rodino Antitrust Improvements Act of 1976

(September 8, 2006): Twenty-eight Annual Report (Fiscal Year 2005).

18

III. Non-Merger Enforcement

A.

Commission Opinions/Initial Decisions

Kentucky Household Goods Carriers Association, Inc.

(June 21, 2004): An administrative law judge upheld an administrative complaint that charged a

group of affiliated intrastate movers with engaging in horizontal price-fixing by filing collective

rates on behalf of its member motor common carriers for the intrastate transportation of property

within the Commonwealth of Kentucky. The judge also ruled that the association’s conduct was

not protected by the state action doctrine because the State of Kentucky did not supervise the

rate-making practices of the group. On July 12, 2004, the Kentucky Household Goods Carriers

Association, Inc. filed an appeal of the initial decision with the Commission. The oral argument

was held January 24, 2005. On June 22, 2005, the Commission issued a unanimous opinion

upholding the Initial Decision finding that the Kentucky Household Goods Carriers Association,

Inc., consisting of competing firms, engaged in illegal price-fixing by jointly filing tariffs

containing collective rates on behalf of its members, and that the state action doctrine does not

immunize that activity from antitrust liability. On August 22, 2006, the Sixth Circuit Court of

Appeals affirmed the opinion of the Commission in Kentucky Household Goods Carriers

Association, Inc., finding that the Association’s ratemaking activities constituted unlawful price

fixing and were not exempt from the antitrust laws under the state action doctrine.

The administrative complaint issued on July 8, 2003 by the Commission charged that the

association composed of competing household goods movers filed collective rates for intrastate

moving services in the state of Kentucky. According to the complaint, these activities were not

protected under the state action doctrine and are not immune from federal antitrust scrutiny.

North Texas Specialty Physicians

(November 8, 2004): An administrative law judge upheld the administrative complaint that

charged that the North Texas Specialty Physicians, a physician group practicing in Forth Worth,

Texas, collectively determined acceptable fees for physician services in negotiating contracts

with health insurance plans and other third party payers. The judge ruled that complaint counsel

proved that North Texas Specialty Physicians engaged in horizontal price fixing. The

accompanying order prohibits the group from negotiating, on behalf of its members, collective

pricing of contracts with health plan services for the provision of physician services. On January

14, 2005, North Texas Specialty Physicians filed a notice of appeal of the initial decision. On

December 1, 2005, the Commission issued a unanimous decision upholding the allegations that

North Texas Specialty Physicians negotiated agreements among participating physicians on price

and other terms, refused to negotiate with payers except on terms agreed to among its members,

and refused to submit payor offers to members if the terms did not satisfy the group’s demands.

The Commission concluded that the group’s contracting activities with payors “amount[s] to

unlawful horizontal price fixing” and that respondent’s efficiency claims were not legitimate and

not supported by the evidence. The respondent has appealed the Commission decision to the

U.S. Court of Appeals for the Fifth Circuit. On March 7, 2007, the Fifth Circuit Court of

Appeals heard oral arguments in the appeal by respondents of the Commission's opinion in North

Texas Specialty Physicians.

19

The administrative complaint, issued on September 16, 2003 by the Commission, charged

that the corporation of 600 physicians negotiated the price and other terms of medical services

that its participating physicians would accept in contracting with third party payers. According

to the complaint, the exchange of prospective price information among otherwise competing

physicians reduced competition and enabled the physicians to achieve supra-competitive prices.

Rambus, Inc.

(June 19, 2002) The Commission filed a complaint with an administrative law judge charging

that between 1991 and 1996 Rambus, Inc. joined and participated in the JEDEC Solid State

Technology Association (JEDEC), the leading standard-setting industry for computer memory.

According to the complaint, JEDEC rules require members to disclose the existence of all

patents and patent applications that relate to JEDEC’s standard-setting work. While a member of

JEDEC, Rambus observed standard-setting work involving technologies which Rambus believed

were or could be covered by its patent applications, but failed to disclose this to JEDEC. In 1999

and 2000, after JEDEC had adopted industry-wide standards incorporating the technologies at

issue and the industry had become locked in to the use of those technologies, Rambus sought to

enforce its patents against companies producing JEDEC-compliant memory, and in fact has

collected substantial royalties from several producers of DRAM (dynamic random access

memory).

(February 17, 2004) The administrative law judge dismissed all charges against Rambus,

ruling that Commission staff had failed to sustain their burden of proof with respect to all three

violations alleged in the complaint. The Initial Decision found that Rambus’ conduct before the

JEDEC standard-setting organization did not amount to deception and did not violate any

extrinsic duties, such as a duty of good faith to disclose patents or patent applications. The

Initial Decision also found that the there was insufficient evidence that there were viable

alternatives to Rambus’ technology before the standard setting organization.

(August 2, 2006) The FTC issued an opinion by Commissioner Pamela Jones Harbour

concluding that Rambus unlawfully monopolized markets for four computer memory

technologies that have been incorporated into industry standards DRAM chips. DRAMs are

widely used in personal computers, servers, printers, and cameras. The Commission found that,

through a course of deceptive conduct, Rambus was able to distort a critical standard-setting

process and engage in an anticompetitive “hold up” of the computer memory industry. The

Commission held that Rambus’s acts of deception constituted exclusionary conduct under

Section 2 of the Sherman Act and contributed significantly to Rambus’s acquisition of monopoly

power in the four relevant markets.

(February 5, 2007) Chairman Majoras issued the opinion of the Commission on remedy

in the Rambus matter. In this opinion, the Commission prescribed a set of remedies barring

Rambus from making misrepresentations or omissions to standard-setting organizations,

requiring Rambus to license its SDRAM and DDR SDRAM technology and setting limits to the

royalty rates it can collect under the licensing agreements including with those firms that may

have already incorporated its DRAM technology, and requiring Rambus to employ a

Commission-approved compliance officer to ensure it discloses relevant patent information to

any standard-setting organizations in which it participates.

20

South Carolina State Board of Dentistry

(July 30, 2004) The Commission denied the motion of the Board to dismiss the complaint on

grounds that its actions were protected from antitrust scrutiny under the state action doctrine.

The South Carolina State Board of Dentistry brought an interlocutory appeal to the Fourth

Circuit Court of Appeals arguing that the denial of immunity under the State Action doctrine was

a collateral order that could be appealed before a final decision. On May 1, 2006, the Fourth

Circuit Court of Appeals dismissed the appeal for lack of jurisdiction, and subsequently, the

Supreme Court denied the board’s petition for certiorari.

An administrative complaint issued on September 12, 2003 charged that the South

Carolina State Board of Dentistry prevented dental hygienists from providing dental care and

services on-site to children in South Carolina schools. According to the complaint, the Board

passed regulation that required the children to have a dentist examine the children before they

would be eligible for the school dental program. The complaint further alleged that this provision

decreased competition in the delivery of preventive dental services to school-aged children. On

July 30, 2004,

Union Oil of California

(November 25, 2003): An administrative law judge dismissed a complaint in its entirety against

Union Oil of California that charged the company with committing fraud in connection with

regulatory proceedings before the California Air Resources Board regarding the development of

reformulated gasoline. The judge ruled much of Unocal’s conduct was permissible activity

under the Noerr-Pennington doctrine and that the resolution of the issues outlined in the

complaint would require an in depth analysis of patent law which he believed were not with the

jurisdiction of the Commission. In July 2004, the Commission reversed the judge’s ruling and

reinstated charges that Unocal illegally acquired monopoly power in the technology market for

producing a “summer-time” low-emissions gasoline mandated for sale and use by the California

Air Resources Board for use in the state for up to eight months of the year. While the case was

pending before the administrative law judge, a consent agreement was signed

B.

Court Decisions

PolyGram Holding, Inc. (The Three Tenors)

(July 24, 2003): The Commission upheld the ruling of an administrative law judge and

prohibited PolyGram from entering into any agreement with competitors to fix the prices or

restrict the advertising of products they have produced independently. The administrative

complaint, issued on July 30, 2001, generally known as The Three Tenors and involving

respondents PolyGram Holding, Inc.; Decca Music Group Limited; UMG Recordings Inc.; and

Universal Music & Video Distribution Corporation charged PolyGram with entering into an

illegal price fixing agreement not to advertise or discount earlier albums and video recordings of

concerts featuring the Three Tenors in an effort to promote the latest concert, thought to be less

appealing to the public. The Commission ordered the respondents to cease and desist from

entering into any combination, conspiracy, or agreement - with producers or sellers at wholesale

of audio or video products - to “fix, raise, or stabilize prices or price levels” in connection with

the sale in or into the United States of any audio or video product. In July 2005, the U.S. Court

of Appeals for the District of Columbia Circuit affirmed the Commission’s decision in Polygram

21

Holding Inc., validating the Commission’s approach to analyzing horizontal conduct among

competitors.

Schering-Plough Corporation

(March 8, 2005) The United States Court of Appeals for the Eleventh Circuit set aside and

vacated the Commission decision that found that Schering-Plough entered into agreements with

Upsher-Smith Laboratories, Inc. and American Home Products to delay the entry of generic

versions of Schering’s branded K-Dur 20, a prescribed potassium chloride supplement. The

Commission filed a petition for writ of certiorari with the U.S. Supreme Court in August 2005,

arguing that the lower court failed to recognize how some agreements limiting entry during the

term of a patent can still be improper; the decision jeopardizes particularly important consumer

interests; and the court of appeals misapplied the substantial evidence standard of review. The

Supreme Court denied the petition.

In the complaint dated March 30, 2001 the Commission alleged that Schering - Plough,

the manufacturer of K-Dur 20 - a prescribed potassium chloride, used to treat patients with low

blood potassium levels - entered into anticompetitive agreements with Upsher-Smith

Laboratories and American Home Products Corporation to delay their generic versions of the KDur 20 drug from entering the market. According to the charges, Schering-Plough paid UpsherSmith $60 million and paid American Home Products $15 million to keep the low-cost generic

version of the drug off the market. The charges against American Home Products were settled

by a consent agreement.

An initial decision filed July 2, 2002 dismissed all charges against Schering - Plough and

Upsher-Smith Laboratories. On December 8, 2003 the Commission reversed the administrative

law judge’s initial decision that had dismissed all charges. The Commission found that

Schering-Plough Corporation entered into agreements with Upsher-Smith Laboratories, Inc. and

American Home Products to delay the entry of generic versions of Schering’s branded K-Dur 20.

According to the opinion, the parties settled patent litigation with terms that included

unconditional payments by Schering in return for agreements to defer introduction of the generic

products. The Commission entered an order that would bar similar conduct in the future.

C.

Authorizations to Seek Preliminary/Permanent

Injunctions

Alpharma, Inc. and Perrigo Company

(August 11, 2004): The Commission authorized staff to file a complaint in federal district court

charging that Alpharma, Inc. and Perrigo Company drove up the prices for over-the-counter

store-brand children’s liquid ibuprofen through an agreement eliminating competition between

the two firms and allowing Perrigo to raise its prices creating higher profits to then be shared

between the firms. According to the complaint, while both Alpharma and Perrigo filed for U.S.

Food and Drug Administration approval to sell a generic version of children’s liquid Motrin,

Alpharma was eligible to sell its product at least six months before approval would be granted to

Perrigo. The two companies entered into an agreement not to compete whereby Perrigo would

sell the children’s liquid ibuprofen for seven years and Alpharma, while would not marketing a

competing product, would receive an up-front payment and a royalty on Perrigo’s sales of the

product. To settle the charges, Alpharma and Perrigo paid a total of $6.25 million in illegal

22

profits and agreed not to enter into agreements not to compete when one party to the agreement

is a first filer of an abbreviated new drug application.

Warner Chilcott

(November 5, 2005) A complaint was filed in District Court for the District Columbia seeking to

put an end to an agreement between drug manufacturers Galen Chemicals Ltd. (now known as

Warner Chilcott) and Barr Laboratories that denies consumers the choice of a lower-priced

generic version of Warner Chilcott’s Ovcon® oral contraceptive. According to the FTC’s

complaint, Barr planned to launch a generic version of Ovcon as soon it received regulatory

approval from the Food and Drug Administration. Warner Chilcott expected to lose half its

Ovcon sales within the first year if Ovcon faced competition from a generic equivalent. Faced

with this prospect, instead of competing with Barr, Warner Chilcott entered into an agreement

with Barr, preventing entry of Barr’s generic Ovcon into the United States for five years. In

exchange for Barr’s promise not to compete, Warner Chilcott paid Barr $20 million.

In September 2006, under the threat of a preliminary injunction sought by the Commission,

Warner Chilcott waived the exclusionary provision in its agreement, and the next day Barr

announced its intention to start selling generic Ovcon in the United States. Under the terms of

the October 2006 order settling the Commission’s charges, Warner Chilcott agreed to certain

terms to protect generic entry into the market. Though Warner Chilcott settled, the FTC’s case

against Barr continues.

D.

Consent Orders

Advocate Health Partners

(Final Order February 9, 2007) The final consent order settles charges that the conduct of several

organizations representing more than 2,900 independent Chicago-area physicians for agreeing to

fix prices and for refusing to deal with certain health plans except on collectively determined

terms. The order will prohibit the respondents from engaging in such anticompetitive conduct in

the future.

Alabama Trucking Association, Inc.

(Final Order October 28, 2003) With an administrative complaint issued on July 8, 2003 the

Commission charged that the association of household goods movers engaged in the collective

filing of tariffs on behalf of its members who compete in the provision of moving services in the

state of Alabama. Under terms of a final consent order, Alabama Trucking Association, Inc.

agreed to stop filing tariffs containing collective intrastate rates and to void collectively filed

tariffs currently in effect in Alabama.

American Institute for Conservation of Historic and Artistic Works

(Final Order October 30, 2002): A consent order settled charges that the American Institute for

Conservation of Historic and Artistic Works adopted and enforced provisions in its rules of

conduct that prohibited professional conservators to work for free or at reduced fees. The

association agreed to remove all provisions from its Code of Ethics, and its Commentaries to the

Guidelines for Practice that are inconsistent with the order. Professional conservators manage

23

and preserve cultural objects (including historical scientific, religious, archaeological and artistic

objects).

Anesthesia Service Medical Group, Inc. and Grossmont Anesthesia Services Medical

Group

(Final Order July 11, 2003): Two anesthesiologists groups settled charges that they entered into

joint agreements to establish fees and services from Grossmont Medical Hospital in San Diego

County. Specifically, the groups agreed on fees that both would demand from health care

insurance companies and other third party payers for taking call for obstetrics and providing

services to uninsured emergency room patients. Together, the two groups are composed of

approximately 200 physicians that provide competing anesthesiology services in the San Diego

area.

Austin Board of Realtors

(Final Order September 6, 2006): The Commission entered into a final consent order settling

charges against the Austin Board of Realtors (ABOR) for its practice of preventing consumers

with listing agreements for potentially low-cost, unbundled brokerage services from marketing

their listings on public real estate-related Internet sites. In settling the charges, ABOR is

prohibited from adopting or enforcing any rule that treats one type of real estate listing

agreement more advantageously than any other, or from interfering with its members ability to

enter into any lawful listing agreement with home sellers.

Biovail Corporation

(Final Order October 2, 2002): The Commission charged Biovail Corporation with illegally

acquiring an exclusive patent license for Tiazac, a pharmaceutical used to treat high blood

pressure and chronic chest pain. The complaint further alleged that Biovail, in an effort to

maintain its monopoly, wrongfully listed the acquired license in the U.S. Food and Drug

Administration’s “Orange Book” for the purpose of blocking generic competition to its branded

Tiazac. The consent order requires Biovail to divest part of its exclusive rights to DOV;

prohibits the firm from taking any action that would trigger additional statutory stays on final

FDA approval of a generic form of Tiazac; and also prohibits Biovail from wrongfully listing

any patents in the Orange Book for a product for which the company already has an New Drug

Application from the FDA.

Bristol-Myers Squibb Company

(Final Order April 14, 2003): Bristol-Myers Squibb Company (BMS) settled charges that it

engaged in illegal business practices to delay the entry of three low price generic

pharmaceuticals that would be in direct competition with three of its branded drugs. The

complaint alleged that BMS purposely made wrongful listings in the Orange Book of the U.S.

Food & Drug Administration and that it also paid a potential competitor over $70 million to

delay the entry of its generic drug. The three drugs involved in the complaint are: Taxol

(containing the active ingredient paclitaxel) – used to treat ovarian, breast, and lung cancers;

Platinol (containing the active ingredient cisplatin) – used for the treatment of various forms of

cancer; and BuSpar (containing the active ingredient buspirone) – used to manage anxiety

disorders.

24

California Pacific Medical Group dba Brown and Toland Medical Group

(Final Order February 3, 2004): With an administrative complaint issued on July 8, 2003 the

Commission charged a San Francisco, California physicians’ organization with engaging in an

agreement under which its competing members agreed collectively on the price and other terms

on which they would enter into contracts with health plans or other third party payers. The

complaint also alleged that Brown and Toland directed its physicians to end their preexisting

contracts with payers and required its physician members to charge specified prices in all

Preferred Provider Organization contracts. A final consent order prohibits Brown and Toland

from negotiating with payers on behalf of physicians, refusing to deal with payers, and setting

terms for physicians to deal with payers, unless the physicians are clinically or financially

integrated.

Carlsbad Physician Association

(Final Order June 13, 2003): A New Mexico physician organization settled charges that it and its

members entered into agreements to fix prices and to refuse to deal with third party payers and

other health care plans except on collectively agreed-upon terms.

Clark County, Washington Attorneys

(Final Order July 23, 2004): Private attorneys in Clark County, Washington who provide

criminal legal services for indigent defendants under a county contract settled charges that they

illegally entered into an agreement known as the “Indigent Defense Bar Consortium Contract” to

collectively demand higher fees for certain types of cases and refuse to accept specific additional

cases unless the Clark County complied with their demands. The county was forced to

substantially increase the reimbursement rate for each of the case categories specified in the

Consortium Contract. According to the Commission, the conduct of the attorneys was identical

to the boycott staged by criminal defense attorneys in Washington, DC which was ruled to be

price fixing by the U.S. Supreme Court in the matter of Superior Court Trial Lawyers

Association. Robert Lewis, James Sowder, Gerald Wear, and Joel R. Yoseph, the four attorneys

who led the activities and served as the representatives of the 43 attorneys who signed the

Consortium Contract, were named in the complaint and in the consent order.

Evanston Northwestern Healthcare Corporation

(Final Order May 17, 2005): Under terms of a consent order, Evanston Northwestern Healthcare

Corporation agreed not to collectively negotiate fee-for-service contracts. The order settled

charges of one count of an administrative complaint issued February 10, 2004. The count

alleged that a physician group associated with a hospital negotiated prices for several hundred

independent physicians who were not financially or clinically integrated with the group.

Health Care Alliance of Laredo, L.C.,

(Final Order March 28, 2006): A physicians’ independent practice association in Texas agreed to

settle charges that it engaged in unlawful collective bargaining to set fees its members would

accept from health insurance plans and advised its members against dealing individually with

plans. The Commission charged that both practices resulted in higher medical costs for

consumers. The consent order settling the FTC’s charges will prohibit the IPA from engaging in

such anticompetitive conduct in the future.

25

Indiana Household Movers and Warehousemen, Inc.

(Final Order April 25, 2003): The corporation that represents household goods movers in Indiana

settled charges that it filed collective intrastate rate tariffs with the State’s Department of

Revenue on behalf of its members. According to the complaint issued with the consent order,

these collective filings reduced competition for household goods moving services within the

state.

Information and Real Estate Services, LLC.

(Final Order December 1, 2006): The Commission settled charges that Information and Real

Estate Services, LLC (IRES) adopted rules that withheld valuable benefits of the Multiple

Listing Services (MLSs) they control from consumers who chose to enter into non-traditional

listing contracts with real estate brokers. The consent order settling the FTC’s charges will

prohibit IRES from discriminating against non-traditional listing arrangements.

Institute of Store Planners

(Final Order May 27, 2003): Under the terms of a final consent order, The Institute of Store

Planners is required to remove from its Code of Ethics any provision that prohibits its members

from providing their services for free and any provision that prohibits competition with other

members for work on the basis of price. Its members provide architectural store design and store

and merchandise planning to retail stores.

Iowa Movers and Warehousemen’s Association

(Final Order September 10, 2003): The Iowa Movers and Warehousemen’s Association settled

allegations that it filed collectively established tariffs for intrastate moving rates in Iowa - a

practice which did not meet the requirements of the state action doctrine. Under the state action

doctrine, some practices of private firms are protected against scrutiny by the federal antitrust

laws.

Maine Health Alliance

(Final Order August 27, 2003): A network of doctors, hospitals, and its executive director,

William R. Diggins, settled charges that they illegally engaged in price-fixing activities that

raised health care costs in five Maine counties by negotiating jointly with third-party payers in a

effort to obtain higher compensation and more advantageous contract terms for its members.

Memorial Hermann Health Network Providers

(Final Order January 18, 2004): Memorial Hermann Health Network Providers settled charges

that it negotiated fees and other services for medical care provided by its member physicians in

the Houston, Texas area in an effort to obtain higher fees and more advantageous terms.

According to the complaint these alleged price fixing practices increased costs for consumer,

employers, and health plans.

Minnesota Transport Services Association

(Final Order September 15, 2003): A consent order settled charges that the household goods

movers association filed collectively established rate tariffs for its members in Minnesota,

conduct that was not protected by the state action doctrine. Under a state action doctrine, some

26

private companies may be protected from the federal antitrust laws if the state authority regulates

and regularly reviews the operations and practices of the companies.

MiRealSource, Inc.

(Final Order March 23, 2007): The Commission filed a Part 3 administrative complaint

challenging a set of rules adopted by MiRealSource, Inc. to keep Exclusive Agency Listings

from being listed on its MLS, as well as other rules that restricted competition in real estate

brokerage services. The complaint alleges that the conduct was collusive and exclusionary,

because in agreeing to keep non-traditional listings off the MLS or from public Web sites, the

brokers enacting the rules were, in effect, agreeing among themselves to limit the manner in

which they compete with one another, and withholding valuable benefits of the MLS from real

estate brokers who did not go along. On February 5, 2007 the Commission approved a consent

order for public comment settling the complaint. Under the terms of the final consent order,

MiRealSource has agreed to abandon such collusive conduct and provide its services to all

member brokers representing potential home sellers, regardless of the type of listing contract that

they choose.

Missouri Board of Embalmers and Funeral Directors

(Proposed Consent Agreement Accepted for Public Comment on March 9, 2007): Under the

terms of the proposed consent order, the Missouri Board of Embalmers and Funeral Directors

(Board) agreed to settle charges that it deterred competitive entry in the retail sale of caskets by

adopting a rule that only licensed funeral directors could sell caskets to consumers on an at-need

basis. Under the proposed settlement, the Board must include in various forms of

communications to the publics that it is not necessary to obtain a license from the Board to offer

for retail sale caskets and other funeral merchandise to customers in Missouri.

Monmouth County Association of Realtors

(Final Order December 1, 2006): The Commission settled charges that Monmouth County

Association of Realtors (Monmouth) adopted rules that withheld valuable benefits of the

Multiple Listing Services (MLSs) they control from consumers who chose to enter into nontraditional listing contracts with real estate brokers. The consent order settling the FTC’s

charges will prohibit Monmouth from discriminating against non-traditional listing

arrangements.

Movers Conference of Mississippi, Inc.

(Final Order October 28, 2003): With an administrative complaint issued on July 8, 2003 the

Commission charged that the association composed of competing household goods movers filed

collective rates for intrastate moving services in the state of Mississippi. According to the

complaint, these activities were not protected under the state action doctrine and are not immune

from federal antitrust scrutiny. Under terms of a final consent order the Movers Conference

agreed to stop filing tariffs containing collective intrastate rates.

National Academy of Arbitrators

(Final Order January 13, 2003): The National Academy of Arbitrators is prohibited from

adopting policies that restrict its members from advertising truthful information about their

services, including prices and conditions of services, under terms of a consent order. The

27

association is required to remove all provisions that do not conform to the provisions in the

consent order from: (1) its Code of Professional Responsibility for Arbitrators of LaborManagement Disputes; (2) its Formal Advisory Opinions; (3) any Statements of Policy; and (4)

its Web site.

New Hampshire Motor Transport Association

(Final Order December 4, 2003): The New Hampshire Motor Transport Association settled

charges that it filed tariffs containing rules that called for automatic increases in intrastate rates.

In addition, the organization agreed to void its collectively filed tariffs current in effect in New

Hampshire.

New Century Health Quality Alliance, Inc.

(Final Order October 6, 2006): The Commission approved a final consent order settling

Commission charges alleging that two independent practice associations (IPAs) and 18 member

physician practices in the Kansas City, MO area, refused to deal with health care plans, except

on collectively agreed-upon prices and other terms.

New Millennium Orthopaedics

(Final Order June 13, 2005): The Commission settled charges with two small groups of

orthopaedic physicians in the Cincinnati area that had formed an independent practice

association that jointly negotiated contracts regarding the rates its physician members would

charge health plans and other payors for their services. In addition to the usual prohibitions on

joint negotiations, the Commission’s order disbanded the IPA and prohibited future collective

bargaining.

Northern New England Real Estate Network, Inc.

(Final Order December 1, 2006): The Commission settled charges that Northern New England

Real Estate Network, Inc. adopted rules that withheld valuable benefits of the Multiple Listing

Services (MLSs) they control from consumers who chose to enter into non-traditional listing

contracts with real estate brokers. The consent order settling the FTC’s charges will prohibit

Northern New England Real Estate Network, Inc. from discriminating against non-traditional

listing arrangements.

Partners Health Network, Inc.

(Final Order September 23, 2005): A physician-hospital organization operating in northwestern

South Carolina, agreed to settle charges that it orchestrated and carried out agreements among its

physician members to set the prices they would accept from health plans, and to refuse to deal

with health plans that did not agree to its collectively determined prices. The consent order

settling the FTC’s charges prohibits the PHO from collectively negotiating with health plans on

behalf of its physicians and from setting terms of dealing with purchasers.

Physician Network Consulting, L.L.C.

(Final Order August 27, 2003): The Physician Network Consulting, L.L.C. of Baton Rouge

Louisiana; Michael J. Taylor; Professional Orthopedic Services, Inc; The Bone and Joint Clinic

of Baton Rouge, Inc.; Baton Rouge Orthopaedic Clinic, L.L.C.; and Orthopaedic Surgery

Associates of Baton Rouge, L.L.C. settled charges that they entered into agreements to fix prices

28

and other terms on which they would deal with United HealthCare of Louisiana, Inc., a health

insurance company. Physician Network Consulting is an agent for Professional Orthopedic

Services’ members.

Piedmont Health Alliance, Inc.

(Final Order October 1, 2004): With an administrative complaint issued on December 22, 2003

the Commission charged Piedmont Health Alliance, Inc. with collectively setting prices it

demanded for physician services with third party payers. According to the complaint, the

physician-hospital organization entered into signed agreements on behalf of its member

physicians to participate in all contracts negotiated and to accept the negotiated physician fees.

The complaint further alleges that these practices eliminated price competition among physicians

in the North Carolina counties of Alexander, Burke, Caldwell and Catawba. The complaint also

names ten individual physicians who participated in the alleged price fixing services. On August

10, 2004, the organization and physicians agreed to settle charges that they fixed prices for

medical services. A final consent order prohibited Piedmont Health Alliance, Inc. and the ten

physicians from entering into any such agreements with physicians in the area that negotiate fees

or terms of services with health insurance companies or other third party payers. Also refer to

settlement entered with Tenet Healthcare Corporation (Frye Regional Medical Center, Inc.).

Preferred Health Services, Inc.

(Final Order April 13, 2005): The order prohibits Preferred Health Services from orchestrating

collective agreements and other terms for physician services when negotiating with health

insurance plans and other third party payers. According to the complaint these agreements

among the physician-hospital organization of doctors and the Oconee Memorial Hospital in

northwestern South Carolina to collectively negotiate fees and terms of services could lead to

higher health care costs and limited physician access.

Professionals in Women’s Care

(Final Order October 2, 2002): Eight Denver, Colorado physician groups specializing in

obstetrics and gynecology and their non-physician agent settled allegations that the practice

group and other physicians entered into collective contracts in an effort to increase prices and

terms of services when dealing with health insurance firms and other third-party payers. The

consent order prohibits the following respondents from entering into such agreements in the

future: R.T. Welter and Associates, Inc.; R. Todd Welter; Consultants in Obstetrics and

Gynecology, P.C.; Mid Town Obstetrics & Gynecology, P.C.; Mile High OG/GYN Associates,

P.C.; The OB-GYN, P.C.; The Women’s Health Group, P.C.; Cohen and Womack, M.D., P.C.;

and Westside Women’s Care, L.L.P.

Puerto Rico Association of Endodontists, Corp.

(Final Order August 29, 2006): The Commission approved a final consent order settling charges

alleging that thirty competing association members acted unlawfully by agreeing to set the prices

they would charge dental insurance plans, and by refusing to deal with plans that would not

accept the collectively determined prices.

29

Realtors Association of Northeast Wisconsin, Inc.

(Final Order December 1, 2006): The Commission settled charges that Realtors Association of

Northeast Wisconsin, Inc. adopted rules that withheld valuable benefits of the Multiple Listing

Services (MLSs) they control from consumers who chose to enter into non-traditional listing

contracts with real estate brokers. The consent order settling the FTC’s charges will prohibit

Realtors Association of Northeast Wisconsin, Inc. from discriminating against non-traditional

listing arrangements.

San Juan IPA

(Final Order June 30, 2005): San Juan IPA, Inc., a physicians’ independent practice association

operating in northwestern New Mexico, agreed to settle Commission charges that it orchestrated

and carried out agreements among its member doctors to set the price that they would accept

from health plans, to bargain collectively to obtain the group’s desired price terms, and to refuse

to deal with health plans except on collectively determined price terms. According to the

complaint, the effect of this conduct was higher prices for medical services for the area’s

consumers. The consent order prohibits the association from collectively negotiating with health

plans on behalf of its physicians and from setting their terms of dealing with such purchasers.

This consent involves 120 physicians who make up about 80 percent of the doctors practicing

independently in the area of Farmington, New Mexico.

Southeastern New Mexico Physicians IPA

(Final Order August 6, 2004): A Roswell, New Mexico physicians’ association, Southeastern

New Mexico Physicians IPA, settled charges that it and two of its employees entered into

collective agreements among physician members on fees and refused to deal with health plans

that did not accept the collective agreed-upon terms. According to the complaint, these practices

increased the price of health care in the Roswell area. The consent order prohibits the IPA and

its employees named in the consent from orchestrating agreements between physicians to

negotiate with health insurance plans on behalf of any physician and deal or refuse to deal

individually with any third party payer.

South Georgia Health Partners, L.L.C.

(Final Order October 31, 2003): A Georgia physician-hospital organization and its other

associated physician groups settled charges that they entered into agreements to fix physician

and hospital prices and refused to deal with insurance companies, except on collectively agreedupon terms.

SPA Health Organization dba Southwest Physician Associates

(Final Order July 17, 2003): A physician group in the Dallas/Fort Worth, Texas area settled

charges that it collectively bargained on behalf of its members to negotiate fee schedules with

third party payers and other health insurance companies. According to the complaint, issued

with the consent order, these practices decreased competition and increased prices for the

provision of medical services to area consumers.

Surgical Specialists of Yakima

(Final Order November 11, 2003): The Surgical Specialists of Yakima, Cascade Surgical

Partners, Inc., P.S. and Yakima Surgical Associates, P.S. settled charges that they jointly entered

30

into agreements for their members to fix prices and terms for the provision of medical services

when dealing with health care insurers.

Tenet Healthcare Corporation

(Final Order January 29, 2004): A consent order prohibits Frye Regional Medical Center, Inc., an

acute care hospital in Hickory, North Carolina, and its parent company Tenet Healthcare

Corporation from entering into any agreement to negotiate fees on behalf of any physician

practicing in four North Carolina counties and from refusing to deal with insurance companies

and other payers. Also refer to related administrative complaint issued to Piedmont Health

Alliance. This settlement is the first case in which the Commission has named a hospital as a

participant in an alleged physician price-fixing conspiracy.

Union Oil Company of California

(Final Order August 2, 2005): With an administrative complaint issued on March 4, 2003 the

Commission charged that Union Oil Company of California (Unocal) made misleading

statements concerning its emissions results for the production of “summer-time” gasoline

mandated by the California Air Resources Board (CARB) for use March through October.

According to the complaint, Unocal lead producers of the CARB gasoline to believe that its

research was non-proprietary and in the public interest, while at the same time it failed to

disclose that it had patent pending claims on the research results with the U.S. Patent and

Trademark Office. As a result of the patent being allowed, Unocal is now in a position to

enforce its patent rights – requiring companies that produce the “summer-time” CARB gasoline

to pay substantial royalties to Unocal if they use the patented technology. An initial decision

dismissing the complaint was filed on February 17, 2004.

A consent order settled the Commission’s monopolization complaint against Unocal. Under the

terms of the settlement, Unocal will stop enforcing the relevant reformulated gasoline patents,

which the Commission alleged could have imposed additional costs of over $500 million per

year on California consumers. In addition, Unocal will release all relevant gasoline patents to the

public.

Valassis Communications, Inc.

(Final Order April 28, 2006): Valassis, a leading producer of free-standing newspaper inserts

(FSIs) in the United States, has settled charges that it attempted to collude with News America

Marketing, its only FSI rival, to eliminate competition between the two companies. Under the

consent order settling the FTC’s complaint, Valassis is barred from engaging in collusive

agreements with other FSI publishers or attempting to collude with its competitors.

Virginia Board of Funeral Directors and Embalmers

(Final Order October 1, 2004): The Virginia Board of Funeral Directors and Embalmers settled

charges that it prohibited Virginia funeral directors and service providers from engaging in

truthful advertising to notify consumers of prices and discounts for funeral products and services.

Under terms of the consent order, the Board is prohibited from engaging in such practices in the

future and is required to amend its regulation prohibiting Board licensees from advertising

funeral services including those services that can be contracted prior to the death of the person

whose funeral is being planned.

31

Washington University Physician Network

(Final Order August 22, 2003): A consent order prohibits a St. Louis, Missouri physicians’

organization from negotiating with third party payers on behalf of its member physicians and

from refusing to deal with health insurance companies.

White Sands Health Care System, L.L.C.

(Final Order January 11, 2005): A consent order settled charges that the White Sands Health

Care System refused to deal with health care insurers that resisted the collectively negotiated

prices set by its member physicians and nurse anesthetists. The complaint alleged that these

practices increased costs for health care for consumers in the Alamogordo, New Mexico area.

White Sands, a physician-hospital organization, consists of Alamogordo Physicians, an

independent practice association; Gerald Champion Regional Medical Center, and 31 nonphysician health care providers, including all five nurse anesthetists in the area.

Williamsburg Area Association of Realtors, Inc.

(Final Order December 1, 2006): The Commission settled charges that Williamsburg Area

Association of Realtors, Inc. adopted rules that withheld valuable benefits of the Multiple Listing

Services (MLSs) they control from consumers who chose to enter into non-traditional listing

contracts with real estate brokers. The consent order settling the FTC’s charges will prohibit

Williamsburg Area Association of Realtors, Inc. from discriminating against non-traditional

listing arrangements.

E.

Administrative Complaints

MiRealSource, Inc.

(October 12, 2006): The Commission filed a Part 3 administrative complaint challenging a set of

rules adopted by MiRealSource, Inc. to keep Exclusive Agency Listings from being listed on its

MLS, as well as other rules that restricted competition in real estate brokerage services. The

complaint alleges that the conduct was collusive and exclusionary, because in agreeing to keep

non-traditional listings off the MLS or from public Web sites, the brokers enacting the rules

were, in effect, agreeing among themselves to limit the manner in which they compete with one

another, and withholding valuable benefits of the MLS from real estate brokers who did not go

along. On February 5, 2007 the Commission approved a consent order for public comment

settling the complaint. Under the terms of the proposed consent order, MiRealSource has agreed

to abandon such collusive conduct and provide its services to all member brokers representing

potential home sellers, regardless of the type of listing contract that they choose.

RealComp II Ltd.

(October 12, 2006): The Commission filed a Part 3 administrative complaint challenging a set of

rules adopted by RealComp II Ltd. that prohibited information on Exclusive Agency Listings and

other forms of nontraditional listings from being transmitted from the MLS it maintains to public

real estate Web sites. The complaint alleges that the conduct was collusive and exclusionary,

because in agreeing to keep non-traditional listings off the MLS or from public Web sites, the

brokers enacting the rules were, in effect, agreeing among themselves to limit the manner in

which they compete with one another, and withholding valuable benefits of the MLS from real

estate brokers who did not go along.

32

F.

Other

Public Documents/Policy Statements/Conferences

Enforcement Perspectives on the Noerr-Pennington Doctrine (November 2, 2006): The

report provides enforcement perspectives on the Noerr-Pennington doctrine, which precludes

enforcement of the antitrust laws against certain private acts that urge government action.

Policy Statement on Monetary Equitable Remedies in Competition Cases (July 25, 2003):

The Commission issued a policy statement that identified three factors that will be considered in

determining whether the Commission will seek disgorgement or restitution in competition cases.

First, the Commission will ordinarily seek monetary relief when the underlying violation is clear.

Second, there must be a reasonable basis for calculating the amount of remedial payment. Third,

the Commission will consider the value of seeking monetary relief in light of other remedies

available in the matter including private actions and criminal proceedings.

FTC Antitrust Actions in Pharmaceutical Services and Products (November 8, 2002):

Summary of health care antitrust matters involving the pharmaceutical industry and enforcement

policy prepared by the FTC Health Care Services and Products Division Staff.

Commission Studies/Guidelines

Agreements Filed With the Federal Trade Commission Under the Medicare Prescription

Drug, Improvement, and Modernization Act of 2003: Summary of Agreements Filed in Fiscal

Year 2006: A Report by the Bureau of Competition (January 17, 2007): Summary of

agreements filed with the Commission in fiscal year 2006 (ending September 30, 2006) by

generic and branded drug manufacturers.

Municipal Provision of Wireless Internet: A Report of the Staff of the Federal Trade

Commission (October 10, 2006): The report describes the various wireless Internet technologies

currently in use or under development, identifies a range of operating models that have been used

to provide or facilitate wireless Internet service, summarizes the major arguments for and against

municipal participation, and describes various types of legislative proposals related to municipal

Internet service.

Investigation of Gasoline Price Manipulation and Post-Katrina Gasoline Price Increases: A

Report by the Federal Trade Commission (May 22, 2006): The report details the results of an

intensive, Congressionally-mandated Commission investigation into whether gasoline prices

nationwide were “artificially manipulated by reducing refinery capacity or by any other form of

market manipulation or price gouging practices” and into gasoline pricing by refiners, large

wholesalers, and retailers in the aftermath of Hurricane Katrina.

33

Agreements Filed With the Federal Trade Commission Under the Medicare Prescription

Drug, Improvement, and Modernization Act of 2003: Summary of Agreements Filed in Fiscal

Year 2005: A Report by the Bureau of Competition (April 24, 2006): Summary of agreements

filed with the Commission in fiscal year 2006 (ending September 30, 2005) by generic and

branded drug manufacturers.

Agreements Filed with the Federal Trade Commission under the Medicare Prescription Drug,

Improvement, and Modernization Act of 2003: Summary of Agreements Filed in FY 2004: A

Report by The Bureau of Competition (January 7, 2005): Information regarding the 22

agreements that were filed with the Commission in fiscal year 2004.

The Petroleum Industry: Mergers, Structural Change and Antitrust Enforcement: A Report of

the Staff of the Federal Trade Commission, Bureau of Economics (August 2004): The staff

report describes the Commission’s merger enforcement actions in petroleum-related markets

during the past 20 years; provides an overview of industry trends in production and pricing;

provides an analysis of merger activity for the period 1985 through 2001; and examines trends at

specific industry levels: crude oil production and reserves; bulk transport of crude oil; refining;

bulk transport of refined products; and product terminals and gasoline marketing.

Improving Health Care: A Dose of Competition: A Report by the Federal Trade Commission

and the Department of Justice (July 23, 2004): Joint report to inform consumers, businesses,

and policy-makers on a range of issues affecting the cost, quality, and accessibility of health

care.

Fulfilling the Original Vision: The FTC at 90 (April 2, 2004): Report highlights some of the

Commission’s accomplishments from the past year and outlines several goals to guide the

agency’s twin missions of competition and consumer protection.

Possible Anticompetitive Barriers to E-Commerce: Contact Lenses: A Report from the Staff of

the Federal Trade Commission (March 29, 2004): The staff report concludes that e-commerce

offers consumers greater choices and more convenience in the contact lens market.

Pharmaceutical Agreement Notification Filing Requirements (Effective January 7, 2004):

Agreements between Brand-name and generic pharmaceutical companies regarding the

manufacture, marketing, and sale of generic versions of brand-name drug products are required

to be filed with the Commission and the Department of Justice, pursuant to Section 1112 of the

Medicare Prescription Drug, Improvement, and Modernization Act of 2003.

Slotting Allowances in the Retail Grocery Industry: Selected Case Studies of Slotting

Allowances in Five Product Categories (November 14, 2003): Slotting allowances paid to

certain retailers in certain geographic areas for five product categories: fresh bread, hot dogs, ice

cream and frozen novelties, shelf-stable pasta, and shelf-stable salad dressing.

To Promote Innovation: The Proper Balance of Competition and Patent Law and Policy, A

Report by the Federal Trade Commission (October 2003): The report is the first of two reports

about how to maintain that balance. The report concludes that questionable patents are a

34

significant competitive concern and can harm innovation. The report makes recommendation to

reduce the number of questionable patents that are issued and upheld.

Report of the State Action Task Force: Recommendations to Clarify and Reaffirm the

Original Purposes of the State Action Doctrine to Help Ensure that Robust Competition

Continues to Protect Consumers (September 23, 2003): The staff report concludes that the

scope of the antitrust state action doctrine has expanded dramatically since its articulation by the

Supreme Court. The report recommends clarifications of the doctrine, including more rigorous

application of the “clear articulation” and “active supervision” requirements.

Possible Anticompetitive Barriers to E-Commerce: Wine (July 3, 2003): Staff report concludes

that e-commerce offers consumers lower prices and more choices in the wine market. Report

concludes that state bans on interstate direct shipping imposes the largest regulatory barrier to

expanded e-commerce in wine.

Advisory Opinions

St. John's Health System. Staff letter concerning the provision of pharmaceuticals by St. John's

Regional Health Center, a non-profit hospital, to three hospital-owned pharmacy sites, under the

Non-Profit Institutions Act (September 13, 2006).

Alpena Public Schools. Staff letter concerning a program to transfer pharmaceuticals at cost

between a non-profit hospital and a non-profit public school system (June 16, 2006.)

Suburban Health Organization. Staff letter concerning the antitrust implications of a proposal

to undertake a program involving partial integration among eight independent Suburban Health

Organization member hospitals and the 192 primary care physicians that, in total, they employ

(March 28, 2006).

North Mississippi Health Services. Staff letter concerning the transfer of pharmaceuticals at

cost by non-profit hospital to patients of non-profit clinic and hospice (August 16, 2005).

Stevens Hospital, of Edmonds, Washington. Staff letter concerning the Applicability of the

Non-Profit Institutions Act Amendments to the Robinson-Patman Act to Stevens Proposed

Pricing of Pharmaceuticals (April 18, 2005).

Bristol-Myers Squibb. Staff advised Bristol-Myers Squibb that its proposed settlement with

Teva Pharmaceuticals USA, inc. does not raise issues under Section 5 of the Federal Trade

Commission Act. (May 2004)

Dunlap Memorial Hospital in Orville, Ohio. Staff concluded that Dunlap’s provision of

pharmaceuticals to the Viola Startzman Free Clinic falls within the scope of the Non-Profit

Institutions Act. (January 9, 2004)

35

Medical Group Management Association: Letter from Jeffrey W. Brennan to Gerald

Niederman. An association of medical practice administrators requested an opinion concerning

its proposal to conduct and publish the results of a survey of physician practices. (November 3,

2003)

Partlinx LLC. Letter advising that FTC staff does not presently intend to recommend law

enforcement action in connection with Partlinx’s proposed e-commerce joint venture. (October

10, 2003)

Bay Area Preferred Physicians. Letter advising that FTC staff does not presently intend to

recommend an enforcement action if Bay Area Preferred Physicians establishes a physician

network to create new contracting opportunities between physicians and health plans and other

third-party payers. (September 23, 2003)

Valley Baptist Medical Center. Letter regarding sale of pharmaceuticals to contracted workers

who provide services at VBMC. (March 18, 2003)

Arkansas Children’s Hospital. Letter rgarding sale of pharmaceuticals to patients seen in clinics

that are located on ACH’s campus but are operated by the University of Arkansas for Medical

Sciences. (March 18, 2003)

PriMed Physicians : Letter regarding proposal by physician group to create with other Dayton,

Ohio area physicians an advocacy group to undertake “a campaign to inform and educate the

general public” of policies and procedures by third party payers in Dayton. (February 6, 2003)

Advocacy Filings

Comments of the Federal Trade Commission Staff before the Louisiana State Bar Association

Rules of Professional Conduct Committee regarding proposed rules on lawyer advertising and

solicitation (March 14, 2007).

Joint Amicus Brief Filing with the U.S. Department of Justice in Leegin Creative Leather

Products, Inc., Petitioner, v. PSKS, Inc concerning vertical minimum resale price maintenance

Agreements in the Supreme Court of the United States, On Writ of Certiorari to the United States

Court of Appeals for the Fifth Circuit) (Case No. 06-480) (January 22, 2007).

Joint Amicus Brief Filing with the U.S. Department of Justice in Credit Suisse Securities

(USA) LLC, et al. Petitioners, v. Glen Billing, et al., concerning certain antitrust immunity issues

(In the Supreme Court of the United States, On Writ of Certiorari to the United States Court of

Appeals for the Second Circuit) (Case No. 05-1157) (January 22, 2007).

Comments of the Federal Trade Commission Staff to The Honorable Terry G. Kilgore

Concerning Virginia House Bill No. 945 to regulate the contractual relationship between

pharmacy benefit managers and both health benefit plans and pharmacies (October 2, 2006).

36

Comments of the Federal Trade Commission Staff before the Office of Court Administration of

the New York State Unified Court System concerning proposed amendments to rules governing

attorney advertisement (September 14, 2006).

Joint Amicus Brief Filing with the U.S. Department of Justice in Weyerhauser Co. v. RossSimmons Hardwood Lumber Co., Inc. concerning predatory bidding in the Supreme Court of the

United States, On Writ of Certiorari to the United States Court of Appeals for the Ninth Circuit

(Case No. 05-381) (August 25, 2006)

Joint Comments of the Federal Trade Commission and the Department of Justice to the

Honorable Helene E. Weinstein Regarding New York A.B. A05596 to establish that certain

services related to real estate transactions may be provided only by attorneys (June 21, 2006).

Joint Amicus Brief Filing with the U.S. Department of Justice in Latino Quimica-Amtex, S.A.

et al. v. Atofina S.A. et al. Concerning the D.C. Circuit’s Empagran Decision in the Second

Circuit (Case No.: 05-5754-cv) (June 1, 2006).

Joint Amicus Brief Filing with the U.S. Department of Justice in Weyerhauser Co. v. RossSimmons Hardwood Lumber Co., Inc. concerning predatory bidding in the Supreme Court (Case

No.: 05-381) (May 31, 2006).

Comments of the Federal Trade Commission Staff before the Professional Ethics Committee

of the State Bar of Texas concerning online attorney matching programs (May 26, 2006).

Comments of the Federal Trade Commission Staff to the Honorable Noble E. Ellington

Concerning Louisiana S.B. 642 to define more clearly the type of seller that must be licensed as

an auctioneer (May 26, 2006).

Comments of the Federal Trade Commission Staff before the Department of Commerce Patent

and Trademark Office in the matter of changes to practice for continuing applications, requests

for continued examination practice, and applications containing patentably indistinct claims

(May 3, 2006).

Comments of the Federal Trade Commission Staff to the Honorable Paula Dockery concerning

Florida Senate Bill 282, a bill to allow direct shipment of wine to Florida consumers from

manufacturers inside or outside Florida (April 10, 2006).

Modernization of Antitrust Law: Antitrust Modernization Commission (March 21, 2006)

Comments of the Federal Trade Commission Staff to The Honorable Eric D. Fingerhut

concerning Ohio S.B. 179 to allow direct shipment of wine to Ohio consumers (March 22, 2006).

Comments of Staff of the Federal Trade Commission Bureau of Economics to file a comment

with the Federal Communications Commission regarding the auction of advanced wireless

services licenses (March 10, 2006).

37

Comments of the Federal Trade Commission Staff before the New Jersey Supreme Court

Concerning Attorney Advertising (March 1, 2006).

Comment of the Federal Trade Commission to the Federal Energy Regulatory Commission

Concerning Market-Based Rates for Public Utilities (January 18, 2006).

Comments of Staff of the Federal Trade Commission to the Honorable Bill Seitz Concerning

Ohio H.B. 306 to Amend the Operation of Wine Wholesale Franchises (December 12, 2005).

Federal Trade Commission Civil Remedies: Antitrust Modernization Commission (December 1,

2005).

Statutory Immunities and Exemptions: Antitrust Modernization Commission (December 1,

2005).

The Hart-Scott-Rodino Second Request Process: Antitrust Modernization Commission

(November 17, 2005).

Treatment of Efficiencies in Merger Enforcement: Antitrust Modernization Commission

(November 17, 2005).

Patent Law Reform: Antitrust Modernization Commission (November 8, 2005).

Federal Antitrust Enforcement Institutions : Antitrust Modernization Commission (November

3, 2005).

Joint Comments of the Federal Trade Commission and the Department of Justice to The

Honorable Alan Sanborn Concerning Michigan H.B. 4849, Which Would Impose Minimum

Service Requirements on Real Estate Brokers (October 18, 2005)

State Action Doctrine: Antitrust Modernization Commission (September 29, 2005).

Comments of Staff of the Federal Trade Commission, Bureau of Economics, Bureau of

Competition and the Office of Policy Planning to the Honorable Wesley Chesbro Concerning the

Proposed California Franchise Act to Govern Contractual Relationships Between Beer

Manufacturers and Wholesalers (August 26, 2005).

Comment of the Federal Trade Commission to the Federal Energy Regulatory Commission

Concerning Information Requirements for Available Transfer Capability (August 23, 2005).

Comments of Staff of the Federal Trade Commission to the Federal Energy Regulatory

Commission concerning Long Term Transmission Rights in Markets Operated by Regional

Transmission Organizations and Independent System Operators (August 23, 2005).

38

Brief Amicus Curiae Illinois Tool Works, Inc. et al. v. Independent Ink, Inc. (Supreme Court)

(Case. No. 04-1329)) Supporting Petitioners on the Issue of Whether a Patent is Presumed to

Confer Market Power in a Tying Case (August 5, 2005).

Brief Amicus Curiae Texaco, Inc. v. Dagher et al. (Supreme Court (Case Nos. 04-805 and 04814)). Concerning Whether an Agreement on Pricing Between Joint Venture Owners is a Per se

Violation of the Sherman Act When the Owners do not Compete in those Products (May 31,

2005).

Joint Comments of the Federal Trade Commission and the Department of Justice to the

Honorable Matt Blunt Concerning Missouri H.B. 174 to Impose Minimum Service Requirements

on Real Estate Brokers (May 24, 2005).

Joint Comments of the Federal Trade Commission and the Department of Justice to the

Alabama Senate Concerning Alabama H.B. 156 to Impose Minimum Service Requirements on

Real Estate Brokers (May 12, 2005).

Joint Comments of the Federal Trade Commission and the Department of Justice before the

Texas Real Estate Commission Concerning Proposed Amendments to 22 Tex. Admin Code §

535.2 to Impose Minimum Service Requirements on Real Estate Brokers (April 20, 2005)

Comment of the Federal Trade Commission to the Food and Drug Administration Concerning

Response to Citizen Petition by IVAX Pharmaceuticals Relating to Generic Drug Application

(Apr. 2005).

Comments of Staff of the Federal Trade Commission Bureau of Competition, Bureau of

Economics and the Office of Policy Planning regarding three bills that the Virginia Assembly

considered: HB 2518 - would loosen current restrictions on competition between commercial and

independent optometrists; and HB 160 and SB 272 - would further impair competition between

these groups of eye care professionals. (March 9, 2005)

Comments of Staff of the Federal Trade Commission Bureau of Competition, Bureau of

Economics and the Office of Policy Planning to North Dakota State Senator Richard L. Brown

concerning HB 1332 which might have the unintended consequences of increasing the price of

pharmaceuticals within the state and ultimately decrease the number of North Dakotans with

insurance coverage for pharmaceuticals. (March 8, 2005)

Joint Amicus Brief Filing with the U.S. Department of Justice: Empagran, S.A. v. HoffmannLaRoche, Ltd., No. 01-7115 (D.C. Cir.). International cartels. (February 18, 2005)

Brief Amicus Curiae Teva Pharmaceuticals USA, Inc. v. Pfizer, Inc. Case No. 04-1186 (Fed.

Cir.) Teva, in an effort to market its generic version of Pfizer’s Zoloft drug, sued Pfizer

challenging the patent for Zoloft. (February 11, 2005)

Joint Comments of the Federal Trade Commission and the Department of Justice to Chief

Justice McFarland of the Kansas Supreme Court concerning the Unauthorized Practice of Law

39

Committee of the Kansas Bar Association’s proposal to define the practice of law. (February 4,

2005)

Joint Comments of the Federal Trade Commission and the Department of Justice urging the

Massachusetts Bar Association to narrow or reject a proposal that would reduce competition

between nonlawyers and lawyers to provide certain services. (December 16, 2004)

Joint Comments of the Federal Trade Commission and the Department of Justice to The

Honorable Paul Kujawski, Member of the Massachusetts House of Representatives, concerning

the adoption of HB 180, a bill that would enable nonlawyers to compete with lawyers to perform

certain real estate closing services. (October 12, 2004)

Comments of Staff of the Federal Trade Commission to California Assembly Member Greg

Aghazaian concerning a bill (AB 1960) that requires pharmacy benefit managers to disclose

certain information to purchasers of their services. (September 10, 2004)

Brief Amicus Curiae Cleveland Bar Association v. CompManagement, Inc. (Case No.: UPL

02-04) Matter on appeal from a decision rendered by Ohio’s UPL Board finding that

CompManagement, an actuarial firm, had engaged in the unauthorized practice of law through

its representation of employers in workers’ compensation matters before the Ohio Industrial

Commission. (August 5, 2004)

Joint Brief Amicus Curiae Federal Trade Commission and the Department of Justice Andrx

Pharmaceuticals, Inc. v. Kroger Company, et al. (U.S. Court of Appeals for the Sixth Circuit)

Private antitrust matter concerning an interim settlement of a pharmaceutical patent infringement

case, in which the alleged infringer agreed not to market its product while the infringement

litigation was pending. (July 16, 2004)

Comments of the Federal Trade Commission to the Federal Energy Regulatory Commission

concerning revisions to the conditions under which FERC will permit electric utilities to sell

wholesale power at market rather than regulated rates. (July 16, 2004)

Comments of the Federal Trade Commission to the Federal Energy Regulatory Commission

concerning FERC’s policies governing electric utility procurement of wholesale electric supply

from affiliated generators and through acquisition of affiliated, unregulated generation assets.

(July 14, 2004)

Comments of Staff of the Federal Trade Commission Bureau of Competition, Bureau of

Economics and the Office of Policy Planning to Michigan House Representative Gene DeRosset

on Michigan’s proposed bill 4757, “Petroleum Marketing Stabilization Act”. (June 18, 2004)

Joint Brief Amicus Curiae Federal Trade Commission and the Department of Justice in

Jackson Tennessee Hospital Co., No. 04-5387 (6th Cir.) Brief contends that the district court

improperly concluded that Tennessee Hospital Co. and other defendants were exempt from

antitrust enforcement under the state action doctrine. (June 4, 2004)

40

Joint Brief Amicus Curiae Federal Trade Commission and the Department of Justice in

McMahon v. Advanced Title Services Company of West Virginia. The brief argues that

allowing nonlawyers to compete with lawyers in the provision of real estate settlement services,

including title searching, title reports, closings, and document deliveries, would benefit West

Virginia consumers in a variety of ways. (May 25, 2004)

Comments of the Staff of the Federal Trade Commission Bureau of Competition, Bureau of

Economics and the Office of Policy Planning to Rhode Island Attorney General Patrick C. Lynch

and Deputy Senate Majority Leader Juan M. Pichardo on seven state bills that contain “freedom

of choice” and “any willing provider” provisions for pharmaceutical sales. (April 12, 2004)

Comments of the Staff of the Federal Trade Commission Bureaus of Competition, Consumer

Protection and Economics and the Office of Policy Planning provide comments on Maryland

House Bill 795 which would permit corporate ownership of funeral homes. (April 6, 2004)

Comments of the Staff of the Federal Trade Commission Bureaus of Competition,

Economics, Consumer Protection, the Northeast Regional Office and the Office of Policy

Planning provided comments on three bills that would allow out-of-state vendors to ship wine

directly to New York consumers if the vendors comply with certain regulatory requirements.

(March 30, 2004)

Comments of Staff of the Federal Trade Commission Bureau of Competition, Bureau of

Economics and the Office of Policy Planning to Kansas State Senator Les Donovan regarding

Bill No. 2330 which would bar the “below-cost” sale of motor fuel. (March 16, 2004)

Comments of Staff of the Federal Trade Commission Bureau of Competition, Bureau of

Economics, and the Office of Policy Planning. Comments to the Speaker Pro Tempore of the

Alabama State House of Representatives Concerning the Alabama Motor fuels Marketing Act.

(January 29, 2004)

Joint Comments of the Federal Trade Commission and the Department of Justice on a draft of

the proposed amendment to the Indiana Supreme Court Admissions & Discipline Rule regarding

Unauthorized Practice of Law to the Indiana State Bar Association. (October 10, 2003)

Comments of the Staff of the Federal Trade Commission Bureau of Competition, Bureau of

Economics, and the Office of Policy Planning. Analysis of Wisconsin’s Unfair Sales Act: Letter

to Wisconsin State Representative Shirley Krug. (October 1, 2003)

Comments to the Federal Energy Regulatory Commission regarding proposed revisions to

market-based tariffs and authorization. (August 28, 2003)

Letter sent to New York Attorney Eliot Spitzer. Comments of the Office of Policy and Planning

and the Bureau of Competition stated that there is a significant risk that the Motor Fuel

Marketing Practices Act could harm consumers by reducing competition in the sale of motor

fuels. (July 24, 2003)

41

Application for Approval of Asset transfer Agreements with Affiliated Company, Ameren

Union Electric Company. Comments to the Illinois Commerce Commission regarding the

transfer of generation assets from an unregulated affiliated to its regulated parent utility. (June

18, 2003)

Proposed Amendments to the North Carolina Motor Fuel Marketing Act. Comments of the

Federal Trade Commission’s Bureau of Competition, Bureau of Economics, and the Office of

Planning. Letter to Senator Daniel G. Clodfelter, Chairman of the Judiciary I Committee, stating

that the proposed amendments to the state’s Motor Fuel Marketing Act are not only unnecessary,

but have significant potential to harm consumers by causing them to pay more at the pump.

(May 21, 2003)

Standards for Determining Whether Natural Gas Prices are Constrained by Market Forces.

Comments to the Georgia Public Service Commission regarding proposed standards to determine

whether market forces constrain retail prices for natural gas. (April 24, 2003)

The Potential Effect of Tenet Healthcare Corporation’s Proposed Purchase of Slidell

Memorial Hospital. Letter from Bureau of Competition, Bureau of Economics and the Office of

Policy Planning to Louisiana Attorney General, The Honorable Richard P. Ieyoub, opposing the

proposed acquisition by Tenet Health Care Systems of the Slidell Memorial Hospital. According

to the letter, the proposed acquisition would eliminate competition and probably give Tenet the

opportunity to increase prices unilaterally following the acquisition. (April 1, 2003)

Real Estate Closing Activities. The Commission and the Department of Justice Joint letter to the

Rhode Island House of Representatives on Proposed Bills H.5936 and H.5639: Proposed

Restrictions on Competition from Non-Attorneys. The agencies expressed concerns that the bills

would eliminate competition between non-lawyers and lawyers in the closing of real estate deals

in Rhode Island by requiring a lawyer to close almost all real estate closings. (April 1, 2003)

Competition and the Effects of Price Controls in Hawaii’s Gasoline Market

2003)

(January 28,

Competition and the Effects of Price Controls in Hawaii’s Gasoline Market (January 28,

2003)

In the Matter of Application for FDA Approval to Market a New Drug; Patent Listing

Requirements; Comments of the FTC Before the HHS and FDA (December 23, 2002)

FTC/DOJ Comments on the American Bar Association’s Proposed Model Definition of the

Practice of Law (December 20, 2002)

Ohio House Bill 325 - Physician Collective Bargaining (October 16, 2002)

42

Workshops/Hearings/Conferences

Single-Firm Conduct

Hearings on Single-Firm Conduct sponsored by the Commission and the Department of

Justice. March 7, 2007: Monopoly Power.

Hearings on Single-Firm Conduct sponsored by the Commission and the Department of

Justice. February 9, 2007: Business Testimony.

Hearings on Single-Firm Conduct sponsored by the Commission and the Department of

Justice. January 26, 2007: Business/Academic Testimony.

Hearings on Single-Firm Conduct sponsored by the Commission and the Department of

Justice. January 10, 2007: Business Testimony.

Hearings on Single-Firm Conduct sponsored by the Commission and the Department of

Justice. December 1, 2006: Misleading and Deceptive Conduct.

Hearings on Single-Firm Conduct sponsored by the Commission and the Department of

Justice. November 17, 2006: Loyalty Discounts.

Hearings on Single-Firm Conduct sponsored by the Commission and the Department of

Justice. November 7, 2006: Exclusive Dealing.

Hearings on Single-Firm Conduct sponsored by the Commission and the Department of

Justice. October 27, 2006: Tying.

Hearings on Single-Firm Conduct sponsored by the Commission and the Department of

Justice. October 20, 2006: Tying, Exclusive Dealing, and Loyalty Discounts.

Hearings on Single-Firm Conduct sponsored by the Commission and the Department of

Justice. September 18, 2006: Empirical Perspectives.

Hearings on Single-Firm Conduct sponsored by the Commission and the Department of

Justice. September 6, 2006: International Issues.

Hearings on Single-Firm Conduct sponsored by the Commission and the Department of

Justice. July 10, 2006: Refusals to Deal.

Hearings on Single-Firm Conduct sponsored by the Commission and the Department of

Justice. June 20, 2006: Predatory Pricing.

43

Healthcare

Roundtable on The Economics of the Pharmaceutical Industry (October 20, 2006)

This Roundtable brought together academic economists, government economists and industry

professionals to discuss a number of important topics including the economic impact of direct-toconsumer advertising, spillovers and mergers in pharmaceutical R&D, and the economic

incentives for new drug development.

Conference on Healthcare Information & Competition (April 16, 2004)

This quasi-academic conference, organized by Stanford health economist Dan Kessler, brought

together academics and health policy makers for one day to examine the production of and use of

health care market information by consumers and employers. It examined some effects of

competition in promoting or retarding information use. Aspects of health care quality were also

addressed. Seven papers were presented, and participation included government health care

experts and employers.

Hearings on Healthcare and Competition Law and Policy sponsored by the Commission and

the Department of Justice. September 24 - 26; and 30; October 1, 2003, Washington, DC.

• Physician Product and Market Definition

• Physician Information Sharing

• Physician IPAs - Patterns and Patterns of Integration - Messenger Model

• Physician Unionization; Group Purchasing Organizations

• International Perspectives on Health Care and Competition Law and Policy

• Medicare and Medicaid

• Remedies: Civil/Criminal

Hearings on Healthcare and Competition Law and Policy sponsored by the Commission and

the Department of Justice. June 25 - 26, 2003, Washington, DC.

• Mandated Benefits

• Pharmaceutical: Formulary Issues

• Prospective Guidance

Hearings on Healthcare and Competition Law and Policy sponsored by the Commission and

the Department of Justice. May 27; 29; and 30 and June 10 - 12, 2003, Washington, DC.

• Quality and Consumer Information - Hospitals

• Physicians

• Market Entry

• Long Term Care/Assisted Living Facilities

• Noerr-Pennington/State Action

• Financing Design/Consumer Information Issues

Hearings on Healthcare and Competition Law and Policy sponsored by the Commission and

the Department of Justice. April 21 - 23; May 7 - 8, 2003, Washington, DC.

• Health Insurance Monopoly - Market Definition. Competitive Effects

• Health Insurance Monopoly - Entry and Efficiencies

• Health Insurance Monopsony - Market Definition - Competitive Effects

44

• Health Insurance/Providers: Countervailing Market Power - Most Favored Nation Clauses

• Physician Hospital Organizations

• Qualify and Consumer Information - Overview

Hearings on Healthcare and Competition Law and Policy sponsored by the Commission and

the Department of Justice. March 26 - 28, 2003, Washington, DC.

• Round table discussion on hospital-related issues and an examination of product and

geographic markets for hospitals

• Issues in litigating hospital mergers

Hearings on Healthcare and Competition Law and Policy sponsored by the Commission and

the Department of Justice. February 26 - 28, 2003, Washington, DC. Examined the state of the

healthcare market place and the role of competition, antitrust, and consumer protection in

satisfying citizens’ preferences for high-quality, cost-effective healthcare.

Healthcare Impact of Competition Law & Policy on the Cost, Quality and Availability of

Healthcare and the Incentives for Innovation in the Field. September 9 - 10, 2002

Workshop, Washington, DC.

Intellectual Property and Patent Law

Ideals into Action: Implementing Reform of the Patent System (April 15 - 16, 2004) The

Commission , the National Academy of Sciences, and the Berkeley Center for Law and

Technology sponsored a conference to address patent reform and how it might be implemented.

Town Meetings on Patent System Reform Three meetings in San Jose, California, February

18, 2005; Chicago, Illinois on March 4, 2005; and Boston, Massachusetts on March 18, 2005 to

bring together government officials, business representatives, lawyers and other members of the

patent community to discuss significant recommendations for patent reform made by the

Commission, the National Academies’ Board on Science, Technology and Economic Policy, and

the American Intellectual Property Law Association.

Intellectual Property Law and Policy - Roundtable Discussion (October 25, 2002)

• Competition, Economic, and Business Perspectives on Patent Quality and Institutional

Issues: Competitive Concerns, Prior Art, Post-Grant Review, and Litigation

• Competition, Economic, and Business Perspectives on Substantive Patent Law Issues:

Non-Obviousness and Other Patentability Criteria

• Antitrust Law and Patent Landscapes

• Standard Setting Organizations: Evaluating the Anticompetitive Risks of Negotiating

Intellectual Property Terms and Conditions Before a Standard is Set

• Relationships Between Competitors and Incentives to Compete: Cross Licensing of

Patent Portfolios, Grantbacks, Reach-Through royalties, and Non-Assertion Clauses

www.ftc.gov/opp/intellect/index

45

Antitrust and Intellectual Property Law and Policy

• Patent Pool and Cross-Licensing: When Do They Promote or Harm Competition?

(April 17, 2002)

• Standard-Setting Practices: Competition, Innovation and Consumer Welfare to Deal?

(April 18, 2002)

• The Strategic Use of Licensing: Is There Cause for Concern about Unilateral Refusals

to Deal? (May 1, 2002)

• Patent Settlements: Efficiencies and Competitive Concerns (May 2, 2002)

• Antitrust Analysis of Licensing Practices (May 14, 2002)

• An International Comparative Law Perspective on the Relationship Between

• Competition and Intellectual Property, Parts I and II (May 22 - 23, 2002)

Other

Broadband Connectivity Competition Policy (February 13-14, 2007)

the Federal Trade Commission held a public workshop on “Broadband Connectivity Competition

Policy” bringing together experts from business, government, and the technology sector,

consumer advocates, and academics to explore competition and consumer protection issues

relating to broadband Internet access, including so-called “network neutrality.”

Roundtable on the Economics of Internet Auctions (October 27, 2005)

The Bureau of Economics held a Roundtable on The Economics of Internet Auctions bringing

together academic economists, government economists and industry professionals to discuss

competition, network effects, fraud, lemons problems, inference, and demand estimation.

Competition Policy and the Real Estate Industry (October 25, 2005)

The Federal Trade Commission and the Department of Justice’s (DOJ) Antitrust Division hosted

a joint workshop covering new and innovative brokerage business models, multiple listing

services, and the implications of state-imposed minimum-service requirements.

Oil Industry Merger Effects (January 14, 2005)

The public conference discussed two recent studies that focused on the price effects of mergers

and concentration in the United States petroleum industry.

90th Anniversary Symposium (September 22 - 23, 2004)

The Federal Trade Commission honored the agency’s 90th anniversary and featured over 50

participants, current Commissioners and other agency officials, as well as prominent academics

and practitioners, many of whom are Federal Trade Commission alumnae.

Anticompetitive Efforts to Restrict Competition on the Internet (October 8 - 10, 2002)

The public workshop explored possible anticompetitive efforts to restrict competition on the

Internet.

46

IV. International Activities

In February of 2007, Chairman Majoras created the FTC’s Office of International Affairs to

coordinate more effectively the full range of the FTC’s international activities. The move brings

international antitrust, consumer protection, and technical assistance programs under one office.

Cooperation with antitrust agencies abroad is a key component of the FTC=s competition

enforcement agenda, resulting in closer collaboration on cross-border actions, and convergence

toward internationally consistent consumer welfare-based competition policies. The FTC

routinely coordinates with colleagues in foreign antitrust agencies on the analysis and resolution

of cases of mutual concern. This results in more efficient and effective review of

multijurisdictional mergers and suspected anticompetitive conduct. Recent examples of

international coordination in merger enforcement include:

$ Boston Scientific/Guidant. Boston Scientific=s proposed $27 billion bid to take over

Guidant raised concerns in several medical device markets, particularly stents and

other devices used to treat vascular diseases. The FTC coordinated its review with the

European Commission (EC), the Canadian Competition Bureau, and the Japan Fair

Trade Commission. The FTC=s review resulted in a consent order requiring the

divestiture of Guidant=s vascular business to an FTC-approved buyer. Canada closed

its investigation because remedies obtained by the FTC and the EC adequately

resolved competition concerns in Canada.

$ Linde/BOC Group. Linde AG=s proposed $14.4 billion acquisition of The BOC

Group plc raised competitive concerns in numerous local markets for atmospheric

gases and in the world market for bulk refined helium (in which a combined

Linde/BOC would have become the largest supplier worldwide). FTC staff worked

with EC and Australian competition agency staff to address these concerns, and

cooperated on the remedial phase of the case to maintain competition in the worldwide

helium market.

Through the OIA, the FTC continues to foster its bilateral ties through consultations in

Washington, D.C. and in foreign capitals, as well as through continued formal and informal case

coordination. The OIA maintains regular contacts with the competition agencies of our major

trading partners such as Canada, Mexico, the European Union (EU) and its members, Japan,

Korea, and Australia. Cooperation with other important jurisdictions such as Brazil, the Russian

Federation, and countries in Central and Eastern Europe continues to grow as well.

The FTC also continues to work closely with the two largest countries in the world,

China and India, as they seek to develop and implement effective competition laws. The FTC

also builds on its strong bilateral relationships to promote policy convergence through formal

and informal working arrangements with other agencies, many of which seek the FTC’s views

on new policy initiatives. Multilateral competition fora provide significant opportunities for

antitrust agencies to promote mutual understanding and further international cooperation. The

FTC participates actively in several such fora, including the International Competition Network

(ICN), the Organization for Economic Cooperation and Development (OECD), the United

47

Nations Conference on Trade and Development (UNCTAD), and the Asia-Pacific Economic

Cooperation (APEC).

V. Competition Speeches

“Vertical Restraints: Federal and State Enforcement of Vertical Issues” (March 8, 2007)

Pamela Jones Harbour, Commissioner. ALI-ABA Course of Study, Product Distribution and

Marketing in Coral Gables, FL.

“A New Direction for Antitrust at the Supreme Court?” (March 1, 2007) Thomas Rosch,

Commissioner. Minnesota State Bar Antitrust Section Meeting in Minneapolis, MN.

“Navigating Between Dystopian Worlds on Network Neutrality, With Misery and

Wretchedness on Each Side, Can We Find A Third Way?” (February 13, 2007) Jon

Leibowitz, Commissioner. FTC Broadband Connectivity Competition Policy Workshop,

Washington D.C.

Keynote Address (February 13, 2007) Deborah Platt Majoras, Chairman. FTC Workshop on

Broadband Connectivity Competition Policy, Washington, D.C.

“Update of Recent Enforcement Activities and Priorities” (February 2, 2007) Jeffrey

Schmidt, Director, Bureau of Competition. 46th Annual Advanced Antitrust Seminar:

Distribution & Marketing. Practicing Law Institute, New York, NY.

“Three Recent Competition Issues at the FTC” (January 5, 2007) Michael A. Salinger,

Director, Bureau of Economics. Industrial Organization Society Session at the American Social

Science Association Meetings, Chicago, IL.

“Monopsony and The Meaning of 'Consumer Welfare,' A Closer Look at Weyerhaeuser”

(December 7, 2006) Thomas Rosch, Commissioner. 2006 Milton Handler Annual Antitrust

Review, New York, NY.

“Merger Policy: Are the Courts and Prosecutors in Sync?” (November 16, 2006) Jeffrey

Schmidt, Director, Bureau of Competition. ABA Fall Forum, Washington, D.C.

“Competition Choke Points?” (November 9, 2006) Thomas Rosch, Commissioner. 2006

Global Forum, Paris, France.

“Remedies” (October 29, 2006) Jeffrey Schmidt, Director, Bureau of Competition. Esapience

Conference in Como, Italy.

“Adoption of Trade Regulations in China, Scope and Effect: An American's View”

(October 20, 2006) Pamela Jones Harbour, Commissioner. New York State Bar Association

International Law and Practice Section Fall 2006 Meeting, Shanghai, China,

48

“How Settlements Make Strange Bedfellows: Or How the Federal Trade Commission has

Managed to Unite the Entire Pharmaceutical Industry (but only in Opposition to the FTC’s

Position on Exclusion Payment Settlements)” (September 29, 2006) Jon Leibowitz,

Commissioner. Generic Pharmaceutical Association's Annual Policy Conference, Washington,

D.C.

“The Legacy of Matsushita: Has this Thing Called Economics Gotten Way Out of Hand?”

(September 29, 2006) Michael A. Salinger, Director, Bureau of Economics. Matsushita at 20,

Loyola University School of Law, Institute for Consumer Antitrust Studies, Chicago, IL.

“A Primer on the Application of Antitrust Law to the Professions in the United States”

(September 29, 2006) William Blumenthal, General Counsel. Annual Fall Conference on

Competition Law of the Canadian Bar Association, Ottawa/Gatineau Canada.

“Lessons from the Masters” (September 28, 2006) Deborah Platt Majoras, Chairman. ABA

Antitrust Section Masters Program, Kiawah Island, SC.

“The Federal Trade Commission in the Online World: Promoting Competition and

Protecting Consumers” (August 21, 2006) Deborah Platt Majoras, Chairman. The Progress &

Freedom Foundation’s Aspen Summit, Aspen CO.

“Looking for the Keys Under the Lamppost: Insights from Economics into Standards for

Unilateral Conduct” (July 24, 2006) Michael A. Salinger, Director, Bureau of Economics.

ABA Section of Antitrust Law, Economics and Section 2 Committees Brown Bag, Washington,

D.C.

“Perspectives on Three Recent Votes: The Closing of the Adelphia Communications

Investigation, the Issuance of the Valassis Complaint & the Weyerhaeuser Amicus Brief”

(July 6, 2006) Thomas Rosch, Commissioner. National Economic Research Associates, 2006

Antitrust & Trade Regulation Seminar, Santa Fe, NM.

“Antitrust Modernization Commission Remarks” (June 8, 2006) Thomas Rosch,

Commissioner. ABA Antitrust Modernization Commission Conference, Georgetown University

Law Center, Washington, D.C.

“A Government Perspective on IP and Antitrust Law” (June 21, 2006) Deborah Platt

Majoras, Chairman. The IP Grab: the Struggle Between Intellectual Property Rights and

Antitrust, American Antitrust Institute, Washington, D.C.

“The Consumer Reigns: Using Section 2 to Ensure a “Competitive Kingdom”“ (June 20,

2006) Deborah Platt Majoras, Chairman. Federal Trade Commission, Washington, D.C.,

“The Relationship between Competition Agencies and Other Units of Government” (May

19, 2006) William Blumenthal, General Counsel. International Seminar on Review of AntiMonopoly Law organized by the Ministry of Commerce, Asian Development Bank, and

Organisation for Economic Cooperation and Development, in Hangzhou, China.

49

“Reflections on the DG Competition Discussion Paper on the Application of Article 82 to

Exclusionary Abuses” (May 11, 2006) Thomas Rosch, Commissioner. 13th Annual

International Competition Law Forum, St. Gallen University, St. Gallen, Switzerland.

“Exclusion Payments to Settle Pharmaceutical Patent Cases: They’re B-a-a-a-ck!

(The Role of the Commission, Congress, and the Courts)” (April 24, 2006) Jon Leibowitz,

Commissioner. Second Annual In-House Counsel’s Forum on Pharmaceutical Antitrust

Philadelphia, PA.

“Promoting a Culture of Competition” (April 10, 2006) Deborah Platt Majoras, Chairman.

Chinese Academy of Social

This text is long and has been trimmed here. Open the source document for the complete record.

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.